Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 29
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

BioTIME 2.0: Expanding and Improving a Database of Biodiversity Time Series

  • Dornelas, Maria|||0000-0003-2077-7055
  • Antao, Laura Henriques|||0000-0001-6612-9366
  • Bates, Amanda E.|||0000-0002-0198-4537
  • Brambilla, Viviana|||0000-0002-0560-4693
  • Chase, Jonathan M.|||0000-0001-5580-4303
  • Cher F. Y. Chow|||0000-0002-1020-8409
  • Fontrodona-Eslava, Ada|||0000-0001-7275-7174
  • Magurran, Anne|||0000-0002-0036-2795
  • Martins, Inês S.|||0000-0003-4328-7286
  • Moyes, Faye|||0000-0001-9687-0593
  • Sagouis, Alban|||0000-0002-3827-1063
  • Adu-Acheampong, Samuel|||0000-0002-6435-2772
  • Acquah-Lamptey, Daniel|||0000-0002-2994-1993
  • Adam, Dušan|||0000-0002-6475-8975
  • Ajani, Penelope A.|||0000-0001-5364-9936
  • Albaina, Aitor|||0000-0003-3353-6090
  • Almaraz, Pablo|||0000-0003-1416-2695
  • An, Jeongseop|||0000-0002-8779-0724
  • Anderson, Roger Sigismund|||0000-0003-4459-1634
  • Robertson Anderson, Madelaine Jean|||0000-0001-6571-9620
  • Antunes, Alexsander Z.|||0000-0003-4864-9354
  • Arismendi, Ivan|||0000-0002-8774-9350
  • Armbrecht, Linda|||0000-0002-1213-1257
  • Aros-Mardones, Pedro|||0009-0000-1975-8856
  • Kalpuzha Ashtamoorthy, Sreejith|||0000-0002-6268-3973
  • Ayyappan, Narayanan|||0000-0003-4383-557X
  • Badihi, Gal|||0000-0001-5025-906X
  • Bailey, Joseph J.|||0000-0002-9526-7095
  • Baird, Andrew H.|||0000-0001-8504-4077
  • Baird, Mark Edward|||0000-0003-4955-2298
  • Balakrishnan, Sreekumar Vadakkethil|||0000-0003-0762-4337
  • Barão-Nóbrega, José António L.|||0000-0002-4814-2871
  • Barash, Adi|||0000-0003-0432-3045
  • Barbosa, Miguel|||0000-0003-0327-9580
  • Barlow, Jos|||0000-0003-4992-2594
  • Bässler, Claus|||0000-0001-8177-8997
  • Beaumont, Matthieu|||0009-0003-6659-6644
  • Beenaerts, Natalie|||0000-0001-5655-5943
  • Begot, Tiago Octavio|||0000-0002-4879-3869
  • Beiroz, Wallace|||0000-0002-9677-6799
  • Beldade, Ricardo|||0000-0003-1911-0122
  • Bell, David M.|||0000-0002-2673-5836
  • Bellgrove, Alecia
  • Belmaker, Jonathan|||0000-0002-5618-7359
  • Benedetti-Cecchi, Lisandro|||0000-0001-5244-5202
  • Benkwitt, Cassandra E.|||0000-0001-6756-7958
  • Medina-van Berkum, Pamela|||0000-0002-7438-1454
  • Bestelmeyer, Brandon T.|||0000-0001-5060-9955
  • Betts, Matthew G.|||0000-0002-7100-2551
  • Billah, Maxwell Kelvin|||0000-0002-8832-0708
  • Bjorkman, Anne|||0000-0003-2174-7800
  • Błażewicz, Magdalena|||0000-0002-4753-3424
  • Bloch, Christopher P.|||0000-0002-5844-5331
  • Blowes, Shane A.|||0000-0001-6310-3670
  • Bode, Antonio|||0000-0002-9535-2548
  • Bogoni, Juliano A.|||0000-0002-8541-0556
  • Bolger, Thomas|||0000-0001-8437-0735
  • Bonebrake, Timothy C.|||0000-0001-9999-2254
  • Bonsdorff, Erik|||0000-0001-5070-4880
  • Bottarin, Roberta|||0000-0002-6352-3699
  • Brokensha, Luke N.|||0009-0000-3223-7887
  • Brooker, Rob W.|||0000-0002-7014-0071
  • Brooks, Andrew J.|||0000-0002-6651-1204
  • Bruelheide, Helge|||0000-0003-3135-0356
  • Almeida Bueno, Thiago|||0000-0002-0384-4546
  • Laguionie, Claire
  • Lopes Campagnoli, Mariana|||0000-0002-2784-871X
  • Cant, James|||0000-0002-5529-1752
  • Pellegrini Caramaschi, Erica|||0000-0002-3371-4996
  • Caron, Alexandre|||0000-0002-5213-3273
  • Carroll, Tadhg|||0000-0002-4812-6855
  • Caruso, Tancredi|||0000-0002-3607-9609
  • Carvajal-Quintero, Juan|||0000-0001-6758-8118
  • Castaldelli, Giuseppe|||0000-0001-5954-1133
  • Castañeda-Moya, Edward|||0000-0001-7759-4351
  • Castilho, Pedro V.|||0000-0002-9939-7807
  • Zanini Cechin, Sonia|||0000-0003-2632-1681
  • Chaikin, Shahar|||0000-0003-1352-9432
  • Manjunatha Chandrashekara, Uchangi
  • Chase, Tory J.|||0000-0002-2044-136X
  • Allen Chen, Chaolun|||0000-0003-0452-4226
  • Cherem, Jorge José|||0000-0001-9718-9628
  • Choi, Sei-Woong|||0000-0001-6326-399X
  • Christensen, Erica M.|||0000-0002-5635-2502
  • Christianini, Alexander V.|||0000-0002-1538-791X
  • Wing Four Chu, Jackson|||0000-0002-7776-9446
  • Coad, Peter
  • Van Colen, Carl|||0000-0002-9307-4484
  • Comte, Lise|||0000-0001-8030-0019
  • Cooper, Elisabeth J.|||0000-0002-0634-1282
  • Cornelissen, J. H. C.|||0000-0002-2346-1585
  • Cosson, Eddy
  • Cotano, Unai|||0000-0003-1477-7059
  • Crevecoeur, Luc
  • Kyle Crow, Shannan|||0000-0001-9888-6513
  • Cumming, Graeme S.|||0000-0002-3678-1326
  • Daga, Vanessa S.|||0000-0003-3707-716X
  • Damasceno, Gabriella|||0000-0001-5103-484X
  • Daskalova, G.N.|||0000-0002-5674-5322
  • Davies, Claire H.
  • Davis, Robert A.|||0000-0002-9062-5754
  • Day, Frank P.
  • De-La-Zerda, Sussy
  • Deacon, Amy Elizabeth|||0000-0002-7739-2925
  • de Castro-Arrazola, Indradatta|||0000-0001-6558-5730
  • Degraer, Steven|||0000-0002-3159-5751
  • Deonarinesingh, Kharran
  • Diaz-Ricaurte, Juan C.|||0000-0002-4659-0865
  • Dickman, Christopher R.|||0000-0002-1067-3730
  • Dirilgen, Tara|||0000-0001-9687-9651
  • Dolan, Ciaran John|||0000-0002-2602-9026
  • Duffy, J. Emmett|||0000-0001-8595-6391
  • Dunn, Timothy E.
  • Durigan, Giselda|||0000-0003-0693-3154
  • Dwyer, Ciara|||0000-0002-7558-3664
  • Earl, Stevan|||0000-0002-4465-452X
  • Edelist, Dor|||0000-0001-9801-4205
  • Edgar, Graham J.
  • Edmondson, Sally
  • Elgin, Ashley K.|||0000-0001-5728-9843
  • Ellingsen, Kari Elsa|||0000-0002-2321-8278
  • Elmendorf, Sarah C.|||0000-0003-1085-8521
  • Eriksen, Ruth S.|||0000-0002-5184-2465
  • Ernest, S. K. Morgan|||0000-0002-6026-8530
  • Escribano, Ruben|||0000-0002-9843-7723
  • Cabral Eterovick, Paula|||0000-0002-1316-1255
  • Evans, Brian S.|||0000-0001-6081-1794
  • Everett, Jason D.|||0000-0002-6681-8054
  • Evtimova, Vesela|||0000-0002-6358-8011
  • Exton, D.A.|||0000-0001-8885-5828
  • Fairbairn, Andrew J.|||0000-0002-2826-3465
  • Moreli Fantacini, Felipe|||0000-0002-3979-2215
  • Turini Farah, Fabiano|||0000-0003-2406-8766
  • Zanella Farneda, Fábio|||0000-0001-6765-2861
  • Favila, Mario E.|||0000-0002-2737-9327
  • Fernandez-Fournier, Philippe|||0000-0003-3701-7386
  • Fernández-Zapata, Braulio|||0000-0002-0913-289X
  • Ferreira, Diogo F.|||0000-0003-2881-1860
  • Ferronato, Carola|||0000-0002-5189-6746
  • du Feu, Christopher R.
  • Fidelis, Alessandra|||0000-0001-9545-2285
  • Fifield, David A.|||0000-0001-5433-4733
  • Picinatto Filho, Vilmar|||0000-0002-6634-5576
  • Mesquita Filho, Walter|||0000-0003-4695-9471
  • Fitt, Robert N. L.|||0000-0003-1210-095X
  • Flechtmann, Carlos A. H.|||0000-0001-6693-3610
  • Fraser, William R.|||0000-0003-4946-1783
  • Fraser, Donna L.
  • Freixas, Lídia|||0009-0002-1314-0347
  • Fryxell, John
  • Fundakowski, Garrett J.|||0009-0009-7135-3018
  • Stanley Gabara, Scott|||0000-0002-8891-3984
  • Gallois, Elise|||0000-0002-9402-1931
  • García Criado, Mariana|||0000-0001-7480-6144
  • García-Berthou, Emili|||0000-0001-8412-741X
  • Garrabou, Joaquim|||0000-0001-9900-7277
  • Gates, Andrew R.|||0000-0002-2798-5044
  • Cazzolla Gatti, Roberto|||0000-0001-5130-8492
  • Gavioli, Anna|||0000-0001-8222-9287
  • Gavriel, Tal|||0000-0001-8657-0060
  • Gendreau-Berthiaume, Benoit
  • Giam, Xingli|||0000-0002-5239-9477
  • Gjerdrum, Carina
  • Glemnitz, Michael|||0000-0002-6506-1889
  • Godbold, Jasmin Annica|||0000-0001-5558-8188
  • Gómez-Gras, Daniel|||0000-0002-9738-6522
  • Barbosa Gonçalves, Rodrigo|||0000-0001-5623-0938
  • Goold, Andy
  • Gordon, Richard R.
  • Goren, Menachem|||0000-0003-1597-269X
  • Vilas Boas Goulart, Fernando
  • Gould, William A.|||0000-0002-3720-9735
  • Grabowski, Meagan M.|||0000-0001-6653-6666
  • Graham, Nicholas A. J.|||0000-0002-0304-7467
  • Graipel, Maurício Eduardo|||0000-0001-5059-1919
  • Grange, Laura J.|||0000-0001-9222-6848
  • Greenville, Aaron C.|||0000-0002-0113-4778
  • Grossman, Gary D.|||0000-0002-4432-1645
  • Guinder, Valeria A.|||0000-0002-3852-9570
  • Haase, Peter|||0000-0002-9340-0438
  • Haskins, Gary
  • Havstad, Kris
  • Hermanutz, Luise|||0000-0003-0706-7067
  • Hames Hickford, Michael Julian|||0000-0002-0275-6632
  • Hidalgo, Pamela|||0000-0002-5872-7574
  • Higuchi, Pedro|||0000-0002-3855-555X
  • Hoey, Andrew|||0000-0002-4261-5594
  • Van Hoey, Gert
  • Hofgaard, Annika|||0000-0001-6919-5537
  • Holeck, Kristen T.|||0000-0003-2784-8637
  • Hollister, Robert D.|||0000-0002-4764-7691
  • Holmes, Richard T.|||0000-0001-6705-6269
  • Odell Hoogenboom, Mia|||0000-0003-3709-6344
  • Hortal, Joaquín|||0000-0002-8370-8877
  • Horton, Tammy|||0000-0003-4250-1068
  • Hsieh, Chih-Hao|||0000-0001-5935-7272
  • Huffard, Christine L.|||0000-0002-2631-1021
  • Huikkonen, Ida-Maria
  • Hurlbert, Allen H.|||0000-0002-5678-9907
  • Hynes, Julian
  • Irz, Pascal|||0000-0002-2066-8935
  • Macedo Ivanauskas, Natália|||0000-0001-6643-8476
  • Iwayama, Akemi
  • James, Darren K.|||0000-0002-9936-5549
  • Jandt, Ute|||0000-0002-3177-3669
  • Jażdżewska, Anna|||0000-0003-2529-0641
  • Jocque, Merlijn|||0000-0002-7196-7476
  • Johnston, Sophie T.
  • Jones, Samuel E. I.|||0000-0002-8123-986X
  • Jones, Faith A. M.|||0000-0001-6571-714X
  • Jones, Julia A.|||0000-0001-9429-8925
  • Jucevica, Edite|||0000-0002-0710-9450
  • Kagainis, Ugis|||0000-0002-9921-2331
  • Kagami, Maiko|||0000-0003-3086-390X
  • Kang, Jungwon
  • Ke, Xuejia|||0000-0002-4957-6428
  • Keeley, Erin C.
  • Kinnear, Rebecca
  • Klanderud, Kari|||0000-0003-1049-7025
  • Klinck, Uwe
  • van Klink, Roel|||0000-0002-8125-1463
  • Klotz, Stefan|||0000-0003-4355-6415
  • Knockaert, Carolien|||0000-0002-9351-7695
  • Knutsen, Halvor|||0000-0002-7627-7634
  • Koivula, Matti|||0000-0001-6415-4904
  • Kortz, Alessandra|||0000-0002-7473-1987
  • Kriegel, Peter|||0000-0003-4099-5295
  • Kuo, Chao-Yang|||0000-0002-5261-5045
  • Kushner, David J.|||0009-0008-4942-2956
  • Kyerematen, Rosina|||0000-0001-9671-9279
  • Lagarde, Raphaël|||0000-0001-9809-1673
  • Lancaster, Lesley T.|||0000-0002-3135-4835
  • Landau, Ori Frid|||0000-0003-2901-4900
  • Van Landuyt, Wouter|||0000-0002-1915-4486
  • Larson, Eric R.|||0000-0002-9232-5907
  • Lazarus, Mai|||0000-0001-6006-5605
  • Lee, Cheol Min|||0000-0001-9856-6974
  • Lefcheck, Jonathan S.|||0000-0002-8787-1786
  • Lembrechts, Jonas J.|||0000-0002-1933-0750
  • Ferreira de Lima, Renato A.|||0000-0002-1048-0138
  • Guimarães Lima, Romullo|||0000-0001-9394-7997
  • Lima, Nathália G. S.
  • Linares, Cristina|||0000-0003-3855-2743
  • Lindstrom, Sandra C.
  • Lloret, Francisco|||0000-0002-9836-4069
  • Lloyd, John D.|||0000-0002-9143-3789
  • Cardoso Lobato, Cleonice Maria
  • Lodge, David M.
  • Long, Peter Richard|||0000-0003-1535-6141
  • López-Abbate, Celeste|||0000-0003-0264-5833
  • Louzada, Julio|||0000-0002-1481-3112
  • Louzao, Maite|||0000-0002-9997-5144
  • Lugliè, Antonella|||0000-0001-6382-4208
  • Ribeiro Luiz, Micheli|||0000-0003-2169-9394
  • Macdonald, S. Ellen|||0000-0003-1750-1779
  • Madin, Joshua S.|||0000-0002-5005-6227
  • Barroso Magalhães, André Lincoln|||0000-0002-9463-1836
  • Mahabir, Rajindra
  • Maphisa, David|||0000-0002-2248-5606
  • Martin, Thomas Edward|||0000-0003-2347-982X
  • Martins, Marcio
  • Martone, Patrick T.|||0000-0002-6345-1023
  • Matesanz, Silvia|||0000-0003-0060-6136
  • Matsuzaki, Shin-ichiro S.|||0000-0003-2744-1343
  • Matthews, Thomas J.|||0000-0002-7624-244X
  • McCombe Matthews, Iain
  • Maxwell, Connie J.
  • McFarland, Kent P.|||0000-0001-7809-5503
  • McGill, Brian J.|||0000-0002-0850-1913
  • McKnight, Diane|||0000-0002-4171-1533
  • McWilliam, Michael J.|||0000-0001-5748-0859
  • Meador, Jason
  • Meesenburg, Henning|||0000-0002-3035-4737
  • Meier, Kristin|||0009-0003-1966-9679
  • Melecis, Viesturs|||0000-0001-6933-7910
  • Meserve, Peter L.|||0000-0003-2679-0285
  • Meyer, Christoph F. J.|||0000-0001-9958-8913
  • Michelsen, Anders|||0000-0002-9541-8658
  • Roman Miiller, Natali Oliva|||0000-0003-0731-3088
  • Milardi, Marco|||0000-0001-6104-294X
  • Milchakova, Nataliya|||0000-0001-5407-7706
  • Miller, Robert J.|||0000-0002-8350-3759
  • Millett, Jonathan|||0000-0003-4701-3071
  • Moens, Tom|||0000-0001-6544-9210
  • Montag, Luciano F. A.|||0000-0001-9370-6747
  • Moore, Jon|||0000-0001-5592-3214
  • Müller, Jörg|||0000-0002-1409-1586
  • Murali, Akhil|||0000-0001-6149-6458
  • Murray, Shauna Ann|||0000-0001-7096-1307
  • Myers-Smith, I. H.|||0000-0002-8417-6112
  • Myster, Randall W.
  • Nakamura, Masahiro|||0000-0002-9909-3977
  • Nayar, Sasi|||0000-0002-3730-6682
  • Neat, Francis|||0000-0003-0077-9088
  • Nelson, James A.|||0000-0003-4607-3953
  • Nelson, Michael Paul
  • Nikolov, Boris P.|||0000-0001-8818-8607
  • Nouioua, Rym|||0000-0002-6023-9369
  • Ayine Nsor, Collins|||0000-0002-9516-7422
  • O'Connor, Michael|||0000-0003-0880-0486
  • Adzesiwor Obodai, Edward
  • Offland, Amy Marie
  • Ogaya, Romà|||0000-0003-4927-8479
  • Ogura, Hisako
  • Okey, Thomas A.|||0000-0002-2556-0587
  • Olden, Julian D.|||0000-0003-2143-1187
  • Rodrigues Oliveira-Santos, Luiz Gustavo|||0000-0001-9632-5173
  • Oliver, Jeffrey C.|||0000-0003-2160-1086
  • Moland Olsen, Esben|||0000-0003-3807-7524
  • Onipchenko, Vladimir|||0000-0002-1626-1171
  • Oro, Daniel|||0000-0003-4782-3007
  • Ozolins, Davis|||0000-0003-3752-2040
  • Pabis, Krzysztof|||0000-0002-9625-3453
  • Padedda, Bachisio Mario|||0000-0002-0988-5613
  • Palacio, Facundo X.|||0000-0002-6536-1400
  • Paquette, Alain|||0000-0003-1048-9674
  • Trilestari Pardede, Sinta
  • Paterson, David M.|||0000-0003-1174-6476
  • Pausina, Sarah|||0000-0001-7845-0296
  • Pélissier, Raphaël|||0000-0003-4845-5090
  • Pennings, Steven C.|||0000-0003-4757-7125
  • Peñuelas, Josep|||0000-0002-7215-0150
  • Pereira, Felipe Walter|||0000-0002-0888-8804
  • Peroni, Nivaldo|||0000-0002-6770-5377
  • Picó, Sergio|||0000-0002-4016-4670
  • Pilotto, Francesca|||0000-0003-1848-3154
  • Tercio Pinheiro, Hudson|||0000-0002-3143-1474
  • Pizarro, Oscar|||0000-0001-6612-2738
  • Pizzolotto, Roberto|||0000-0002-4587-3476
  • Pomati, Francesco|||0000-0002-9746-3735
  • Santos Pompeu, Paulo|||0000-0002-7938-1517
  • Ponton, Dominique|||0000-0003-2313-2543
  • Post, Eric|||0000-0002-9471-5351
  • Poulet, Nicolas|||0000-0002-5611-0749
  • Pöyry, Juha|||0000-0002-5548-1046
  • Presley, Steven J.|||0000-0002-5987-0735
  • Prins, Herbert H. T.|||0000-0003-1131-5107
  • Provoost, Pieter|||0000-0002-4236-0384
  • Prudic, Kathleen L.|||0000-0001-8242-7769
  • Punjayil, Vignesh|||0009-0004-7194-0259
  • Pyšek, Petr|||0000-0001-8500-442X
  • Querner, Pascal|||0000-0002-3537-0699
  • Quimbayo, Juan Pablo|||0000-0001-5346-3488
  • Ramnarine, Indar W.
  • Reed, Daniel C.|||0000-0003-3015-8717
  • Reich, Peter Bernard|||0000-0003-4424-662X
  • Remillard, Suzanne M.|||0000-0002-0365-8866
  • Richards, Cerren|||0000-0003-0047-8023
  • Richardson, Anthony James|||0000-0002-9289-7366
  • van Rijn, Itai
  • Rivera-Monroy, Victor H.|||0000-0003-2804-4139
  • Rixen, Christian|||0000-0002-2486-9988
  • Robinson, Kevin Peter|||0000-0001-8085-9752
  • Rocha, Ricardo|||0000-0003-2757-7347
  • Rodrigues, Ricardo R.|||0000-0003-4818-0736
  • Rodrigues, Cassy
  • de Roos, Bjørn
  • de Rossa-Feres, Denise de C.|||0000-0002-4537-9064
  • Rosselli, Loreta|||0000-0001-9306-8415
  • Rothlisberg, Peter Charles|||0000-0001-5632-5996
  • Rubio, Ana|||0000-0002-3943-3685
  • Rudstam, Lars G.|||0000-0002-3732-6368
  • Ruz, Catalina S.|||0000-0003-0379-8081
  • Rybicki, Nancy|||0000-0002-2205-7927
  • Van Ryckegem, Gunther|||0000-0001-8788-0001
  • Rypel, Andrew L.|||0000-0002-9812-8306
  • Sadler, Jon P.|||0000-0003-0443-4458
  • Satoru Saito, Victor|||0000-0001-6112-7249
  • Sal, Sofia
  • Portela Salomão, Renato|||0000-0001-9826-7472
  • Sanders, Nathan J.|||0000-0001-6220-6731
  • Santos, Flavio A. M.|||0000-0002-4329-6214
  • Gomes dos Santos, Tiago|||0000-0003-4298-5656
  • Kumar Sarker, Swapan|||0000-0002-9933-0493
  • Scanga, Sara|||0000-0003-4022-4167
  • Schaub, Marcus|||0000-0002-0158-8892
  • Schmidt, Jochen|||0000-0002-1337-7304
  • Schmidt, Inger Kappel|||0000-0003-3880-2060
  • Schooley, Robert|||0000-0001-5951-2340
  • Schultz, Alfred
  • Scotti, Alberto|||0000-0002-5861-7551
  • Serpell-Stevens, Amanda|||0009-0009-1153-3033
  • Serrano, Filipe C.|||0000-0002-8568-678X
  • Shadwick, Elizabeth H.|||0000-0003-4008-3333
  • Shaft, Matthew
  • Sherry, Thomas W.|||0000-0002-5602-2626
  • Mayumi Shimabukuro, Erika|||0000-0001-8377-1844
  • Siciński, Jacek|||0000-0002-5235-3188
  • Sievers, Caya
  • Rodrigues da Silva, Fernando|||0000-0002-0983-3207
  • da Silva, Ana Carolina|||0000-0002-1285-640X
  • Silveira, Juliana M.|||0000-0001-6045-2138
  • Siqueira, Tadeu|||0000-0001-5069-2904
  • Kavidapadinjattathil Sivadasan, Arunkumar|||0009-0003-8261-6094
  • Parambil Sivan, Prasad Theruvil|||0000-0003-1943-6683
  • Skuja, Agnija|||0000-0003-2653-1144
  • Slaughter, Amalia L.
  • Slingsby, Jasper A.|||0000-0003-1246-1181
  • Smith, Joseph R.
  • Eleres Soares, Bruno|||0000-0001-5678-0403
  • Solan, Martin|||0000-0001-9924-5574
  • Maluf Souza, Flaviana|||0000-0002-6162-7849
  • Souza, Gabriel B. G.|||0000-0002-1770-8924
  • Sprague, Joshua L.
  • Stachow, Ulrich|||0000-0003-0406-0812
  • Stadt, J. John|||0000-0003-3398-5646
  • Stallings, Christopher D.|||0000-0002-3410-4540
  • Hristov Stanchev, Radoslav
  • Stanley, Emily H.|||0000-0003-4922-8121
  • Starzomski, Brian M.|||0000-0001-5017-5405
  • Mauro Sterza, Jose
  • Stevens, Maarten|||0000-0003-2251-2878
  • Stiles, F. Gary|||0000-0003-2044-3733
  • Stoll, Stefan|||0000-0002-3656-417X
  • Stuart-Smith, Rick|||0000-0002-8874-0083
  • Rondon Súarez, Yzel|||0000-0003-1226-4321
  • Super, Laura|||0000-0002-5259-8708
  • Supp, Sarah R.|||0000-0002-0072-029X
  • Sutela, Tapio|||0000-0003-4227-9399
  • Suthers, Iain M.
  • Suuronen, Anna
  • Swadling, Kerrie M.|||0000-0002-7620-841X
  • Szydlowski, Daniel K.|||0000-0003-3920-8776
  • Taki, Hisatomo|||0000-0002-2399-0049
  • Snell Taylor, Sara Jeanne|||0000-0002-0353-9613
  • Tedesco, Pablo A.|||0000-0001-5972-5928
  • Teichert, Nils
  • Terui, Akira|||0000-0003-3774-2844
  • Thiede, Gary P.|||0009-0003-2382-7641
  • Thimonier, Anne|||0000-0002-4685-1957
  • Thomas, Oliver|||0000-0002-3443-2149
  • Thompson, Peter Allan|||0000-0002-9504-5433
  • Thorn, Simon|||0000-0002-3062-3060
  • Tiemann, Jeremy S.|||0000-0001-7635-1403
  • Felipe Toledo, Luís|||0000-0002-4929-9598
  • Tolvanen, Anne|||0000-0002-5304-7510
  • Torre, Ignasi|||0000-0002-4803-9524
  • Adriano Tortato, Marcos|||0000-0003-4928-5150
  • Totsu, Kumiko|||0009-0004-0192-3904
  • Trant, Andrew|||0000-0003-3030-530X
  • Twilley, Robert R.|||0000-0002-6173-6033
  • Urabe, Hirokazu|||0000-0002-7771-6037
  • Valade, Pierre|||0000-0001-9744-6153
  • Valdivia, Nelson|||0000-0002-5394-2072
  • Vallejo, Martha Isabel|||0000-0003-1864-1052
  • Valone, Thomas J.|||0000-0002-7657-3126
  • Vanaverbeke, Jan|||0000-0003-2488-8609
  • Silveira Vasconcelos, Tiago|||0000-0002-5762-0513
  • Vehanen, Teppo|||0000-0003-3441-6787
  • Venturoli, Fábio|||0000-0002-2105-5081
  • Verheye, Hans M.|||0000-0002-3110-5695
  • Wietse Vermeulen, Hendrik Jannes
  • Verstraeten, Arne|||0000-0002-8813-1261
  • Vianna, Marcelo|||0000-0001-5871-8152
  • Vieira, Rui|||0000-0001-8491-2565
  • Santos Vieira-Alencar, João Paulo|||0000-0001-6894-6773
  • Vilella, Marc|||0000-0002-0732-0985
  • Simões Vitule, Jean Ricardo|||0000-0001-6543-7439
  • Van Vu, Lien|||0000-0003-2389-9402
  • Waide, Robert B.|||0000-0001-8127-8634
  • Warren, Paige S.|||0000-0003-0787-4635
  • Wayman, Joseph Paul|||0000-0002-3122-8070
  • Webb, Sara L.
  • Weigel, Benjamin|||0000-0003-2302-5529
  • Welti, Ellen A. R.|||0000-0001-6944-3422
  • West, Fritha|||0009-0005-8930-5357
  • Westermann, Fulgor
  • Whalen, Matthew A.|||0000-0002-5262-6131
  • White, Ethan P.|||0000-0001-6728-7745
  • Widdicombe, Claire E.|||0000-0002-1688-0212
  • Williams, Richard
  • Williamson, Mark
  • Willig, Michael R.|||0000-0001-6884-9957
  • Wipf, Sonja|||0000-0002-3492-1399
  • Woehler, Eric J.|||0000-0002-1125-0748
  • Woldering, Alje
  • Woods, Kerry D.|||0000-0003-1029-6995
  • Xu, Wu-Bing|||0000-0002-6566-4452
  • Yahel, Ruthy|||0000-0001-5408-8480
  • Yang, Zeren
  • Zawada, Kyle J. A.|||0000-0002-4587-8138
  • Zornosa-Torres, Camila|||0000-0001-7149-6611
  • Zvuloni, Assaf
Motivation: Here, we make available a second version of the BioTIME database, which compiles records of abundance estimates for species in sample events of ecological assemblages through time. The updated version expands version 1.0 of the database by doubling the number of studies and includes substantial additional curation to the taxonomic accuracy of the records, as well as the metadata. Moreover, we now provide an R package (BioTIMEr) to facilitate use of the database. Main Types of Variables Included: The database is composed of one main data table containing the abundance records and 11 metadata tables. The data are organised in a hierarchy of scales where 11,989,233 records are nested in 1,603,067 sample events, from 553,253 sampling locations, which are nested in 708 studies. A study is defined as a sampling methodology applied to an assemblage for a minimum of 2 years.Spatial Location and Grain: Sampling locations in BioTIME are distributed across the planet, including marine, terrestrial and freshwater realms. Spatial grain size and extent vary across studies depending on sampling methodology. We recommend gridding of sampling locations into areas of consistent size.Time Period and Grain: The earliest time series in BioTIME start in 1874, and the most recent records are from 2023. Temporal grain and duration vary across studies. We recommend doing sample- level rarefaction to ensure consistent sampling effort through time before calculating any diversity metric. Major Taxa and Level of Measurement: The database includes any eukaryotic taxa, with a combined total of 56,400 taxa. Software Format: csv and. SQL.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Empiric therapy with Carbapenem-sparing regimens for bloodstream infections due to extended-spectrum β-Lactamase–producing Enterobacteriaceae: results from the INCREMENT cohort

  • Palacios-Baena, Zaira R.
  • Gutiérrez-Gutiérrez, Belén
  • Calbo, Esther
  • Almirante, Benito
  • Viale, Pier-Luigy
  • Oliver, Antonio
  • Pintado, Vicente
  • Gasch Blasi, Oriol
  • Martínez-Martínez, Luis
  • Pitout, Johann
  • Akova, Murat
  • Peña, Carmen
  • Molina Gil-Bermejo, José
  • Lorenzo-Hernández, Alicia
  • Venditti, Mario
  • Prim, Nuria
  • Bou, Germán
  • Tacconelli, Evelina
  • Tumbarello, Maria
  • Hamprecht, Axel
  • Giamarellou, Helen
  • Almela, Manuel
  • Pérez, Federico J.
  • Schwaber, Mitchell J.
  • Bermejo, Joaquín
  • Lowman, Warren
  • Hsueh, Po-Ren
  • Paño-Pardo, José Ramón
  • Torre-Cisneros, Julián
  • Souli, Maria
  • Bonomo, Robert
  • Carmeli, Yehuda
  • Paterson, David L.
  • Pascual, Álvaro
  • Rodríguez-Baño, Jesús
[Abstract] Background: There is little information about the efficacy of active alternative drugs to carbapenems except β-lactam/β-lactamase inhibitors for the treatment of bloodstream infections (BSIs) due to extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E). The objective of this study was to assess the outcomes of patients with BSI due to ESBL-E who received empiric therapy with such drugs (other active drugs [OADs]) or carbapenems. Methods: A multinational retrospective cohort study of patients with BSI due to ESBL-E who received empiric treatment with OADs or carbapenems was performed. Cox regression including a propensity score for receiving OADs was performed to analyze 30-day all-cause mortality as main outcome. Clinical failure and length of stay were also analyzed. Results: Overall, 335 patients were included; 249 received empiric carbapenems and 86 OADs. The most frequent OADs were aminoglycosides (43 patients) and fluoroquinolones (20 patients). Empiric therapy with OADs was not associated with mortality (hazard ratio [HR], 0.75; 95% confidence interval [CI], .38-1.48) in the Cox regression analysis. Propensity score-matched pairs, subgroups, and sensitivity analyses did not show different trends; specifically, the adjusted HR for aminoglycosides was 1.05 (95% CI, .51-2.16). OADs were neither associated with 14-day clinical failure (adjusted odds ratio, 0.62; 95% CI, .29-1.36) nor length of hospital stay. Conclusions: We were unable to show that empiric treatment with OAD was associated with a worse outcome compared with carbapenems. This information allows more options to be considered for empiric therapy, at least for some patients, depending on local susceptibility patterns of ESBL-E., The study was funded by the Ministerio de Economía y Competitividad-Instituto de Salud Carlos III through the following grants: Acción Estratégica en Salud (PI10/02021 and PI14/01832), and Plan Nacional de I+D+i, Subdirección General de Redes y Centros de Investigación Cooperativa, Spanish Network for Research in Infectious Diseases (REIPI RD 12/0015/0010 and RD16/0016/0001), co-financed by the European Development Regional Fund “A way to achieve Europe,” Operative Programme Intelligent Growth 2014–2020. B. G. G., J. R. B., A. P. H., and Y. C. also received funds from the Innovative Medicines Initiative, the European Union’s Seventh Framework Programme (FP7/2007–2013), and in-kind contributions from European Federation of Pharmaceutical Industries and Associations companies (COMBACTE-CARE project, agreement 115620). R. A. B. was also supported in part by funds and/or facilities provided by the Cleveland Department of Veterans Affairs, the Veterans Affairs Merit Review Program and the Geriatric Research Education and Clinical Center VISN 10 (VISN 10 GRECC), and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) under award numbers R01AI072219 and R01AI063517.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

PRAISE: providing a roadmap for automated infection surveillance in Europe

  • van Mourik, Maaike S. M.
  • van Rooden, Stephanie M.
  • Abbas, Mohamed
  • Aspevall, Olov
  • Astagneau, Pascal
  • Bonten, Marc J.M.
  • Carrara, Elena
  • Gomila Grange, Aina
  • de Greeff, Sabine C.
  • Gubbels, Sophie
  • Harrison, Wendy
  • Humphreys, Hilary
  • Johansson, Anders
  • Koek, Mayke B.G.
  • Kristensen, Brian
  • Lepape, Alain
  • Lucet, Jean-Christophe
  • Mookerjee, Siddharth
  • Naucler, Pontus
  • Palacios Baena, Zaira R.
  • Presterl, Elisabeth
  • Pujol Rojo, Miquel
  • Reilly, Jacqui
  • Roberts, Christopher
  • Tacconelli, Evelina
  • Teixeira, Daniel
  • Tängdén, Thomas
  • Valik, John Karlsson
  • Behnke, Michael
  • Gastmeier, Petra
Introduction: Healthcare-associated infections (HAI) are among the most common adverse events of medical care. Surveillance of HAI is a key component of successful infection prevention programmes. Conventional surveillance - manual chart review - is resource intensive and limited by concerns regarding interrater reliability. This has led to the development and use of automated surveillance (AS). Many AS systems are the product of in-house development efforts and heterogeneous in their design and methods. With this roadmap, the PRAISE network aims to provide guidance on how to move AS from the research setting to large-scale implementation, and how to ensure the delivery of surveillance data that are uniform and useful for improvement of quality of care. Methods: The PRAISE network brings together 30 experts from ten European countries. This roadmap is based on the outcome of two workshops, teleconference meetings and review by an independent panel of international experts. Results: This roadmap focuses on the surveillance of HAI within networks of healthcare facilities for the purpose of comparison, prevention and quality improvement initiatives. The roadmap does the following: discusses the selection of surveillance targets, different organizational and methodologic approaches and their advantages, disadvantages and risks; defines key performance requirements of AS systems and suggestions for their design; provides guidance on successful implementation and maintenance; and discusses areas of future research and training requirements for the infection prevention and related disciplines. The roadmap is supported by accompanying documents regarding the governance and information technology aspects of implementing AS. Conclusions: Large-scale implementation of AS requires guidance and coordination within and across surveillance networks. Transitions to large-scale AS entail redevelopment of surveillance methods and their interpretation, intensive dialogue with stakeholders and the investment of considerable resources. This roadmap can be used to guide future steps towards implementation, including designing solutions for AS and practical guidance checklists.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study

  • Vallejo Torres, Laura
  • Pujol Rojo, Miquel
  • Shaw Perujo, Evelyn
  • Wiegand, Irith
  • Vigo, Joan Miquel
  • Stoddart, Margaret
  • Grier, Sally
  • Gibbs, Julie
  • Vank, Christiane
  • Cuperus, Nienke
  • van den Heuvel, Leonard
  • Eliakim-Raz, Noa
  • Carratalà, Jordi
  • Vuong, Cuong
  • MacGowan, Alasdair
  • Babich, Tanya
  • Leibovici, Leonard
  • Addy, Ibironke
  • Morris, S. (Stephen), 1971-
  • RESCUING Study Group and Study Sites
Objective: Complicated urinary tract infections (cUTIs) impose a high burden on healthcare systems and are a frequent cause of hospitalisation. The aims of this paper are to estimate the cost per episode of patients hospitalised due to cUTI and to explore the factors associated with cUTI-related healthcare costs in eight countries with high prevalence of multidrug resistance (MDR). Design: This is a multinational observational, retrospective study. The mean cost per episode was computed by multiplying the volume of healthcare use for each patient by the unit cost of each item of care and summing across all components. Costs were measured from the hospital perspective. Patient-level regression analyses were used to identify the factors explaining variation in cUTI-related costs. Setting: The study was conducted in 20 hospitals in eight countries with high prevalence of multidrug resistant Gram-negative bacteria (Bulgaria, Greece, Hungary, Israel, Italy, Romania, Spain and Turkey). Participants: Data were obtained from 644 episodes of patients hospitalised due to cUTI. Results: The mean cost per case was 5700, with considerable variation between countries (largest value 7740 in Turkey; lowest value 4028 in Israel), mainly due to differences in length of hospital stay. Factors associated with higher costs per patient were: type of admission, infection source, infection severity, the Charlson comorbidity index and presence of MDR. Conclusions: The mean cost per hospitalised case of cUTI was substantial and varied significantly between countries. A better knowledge of the reasons for variations in length of stays could facilitate a better standardised quality of care for patients with cUTI and allow a more efficient allocation of healthcare resources. Urgent admissions, infections due to an indwelling urinary catheterisation, resulting in septic shock or severe sepsis, in patients with comorbidities and presenting MDR were related to a higher cost.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

EUropean prospective cohort study on Enterobacteriaceae showing REsistance to CArbapenems (EURECA): a protocol of a European multicentre observational study

  • Gutiérrez-Gutiérrez, Belén
  • Sojo-Dorado, Jesús
  • Bravo-Ferrer, José
  • Cuperus, Nienke
  • Kraker, Marlieke de
  • Kostyanev, Tomislav
  • Raka, Lul
  • Daikos, George
  • Feifel, Jan
  • Folgori, Laura
  • Pascual Bravo, Alberto
  • Goossens, Herman
  • O’Brien, Seamus
  • Bonten, Marc J. M.
  • Rodríguez-Baño, Jesús
EURECA project team., [Introduction] The rapid worldwide spread of carbapenem-resistant Enterobacteriaceae (CRE) constitutes a major challenge. The aim of the EUropean prospective cohort study on Enterobacteriaceae showing REsistance to CArbapenems (EURECA), which is part of the Innovative Medicines Initiative Joint Undertaking (IMI JU) funded COMBACTE-CARE project, is to investigate risk factors for and outcome determinants of CRE infections to inform randomised clinical trial designs and to provide a historical cohort that could eventually be used for future comparisons with new drugs targeting CRE., [Methods] A multicentre (50 sites), multinational (11 European countries), analytical observational project was designed, comprising 3 studies. The aims of study 1 (a prospective cohort study) include characterising the features, clinical management and outcomes of hospitalised patients with intra-abdominal infection, pneumonia, complicated urinary tract infections and bloodstream infections caused by CRE (202 patients in each group). The main outcomes will be 30-day all-cause mortality and clinical response. Study 2 (a nested case–control study) will identify the risk factors for target infections caused by CRE; 248 selected patients from study 1 will be matched with patients with carbapenem-susceptible Enterobacteriaceae (1:1) and with hospitalised patients (1:3) and will provide a historical cohort of patients with CRE infections. Study 3 (a matched cohort study) will follow patients in study 2 in order to assess mortality, length of stay and hospital costs associated with CRE. All patients will be followed for 30 days. Different, up-to-date statistical methods will be applied to come to unbiased estimates for all 3 studies., [Ethics and dissemination] Before-study sites will be initiated, approval will be sought from appropriate regulatory agencies and local Ethics Committees of Research or Institutional Review Boards (IRBs) to conduct the study in accordance with regulatory requirements. This is an observational study and therefore no intervention in the diagnosis, management or treatment of the patients will be required on behalf of the investigation. Any formal presentation or publication of data collected from this study will be considered as a joint publication by the participating physician(s) and will follow the recommendations of the International Committee of Medical Journal Editors (ICMJE) for authorship., [Trial registration number] NCT02709408., The EURECA project is funded by the Innovative Medicine Initiative (IMI), European Union's Seventh Framework Programme (FP7/2007–2013) and EFPIA companies' in-kind contribution (COMBACTE-CARE, grant agreement 115 620). JR-B and AP received funding for research from the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015 and RD16/2016), Instituto de Salud Carlos III, MInisterio de Economía y Competitivad, co-financed by the European Development Regional Fund ‘A Way to Achieve Europe’ ERDF; BG-G is the recipient of a Río Hortega grant from Instituto de Salud Carlos III (CM 15/00265)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae

  • Palacios-Baena, Zaira Raquel
  • Gutiérrez-Gutiérrez, Belén
  • Cueto, Marina de
  • Viale, Pierluigi
  • Venditti, Mario
  • Hernández, Alicia
  • Oliver, Antonio
  • Martínez-Martínez, Luis
  • Calbo, Esther
  • Pintado, Vicente
  • Gasch, Oriol
  • Almirante, Benito
  • Lepe, José A.
  • Pitout, Johann
  • Akova, Murat
  • Peña, Carmen
  • Schwaber, Mitchell J.
  • Tumbarello, Mario
  • Tacconelli, Evelina
  • Origüen, Julia
  • Prim, Nuria
  • Bou, Germán
  • Giamarellou, Helen
  • Bermejo, Joaquín
  • Hamprecht, Axel
  • Pérez, Federico
  • Almela, Manel
  • Lowman, Warren
  • Hsueh, Po-Ren
  • Navarro-San Francisco, Carolina
  • Torre-Cisneros, Julián
  • Carmeli, Yehuda
  • Bonomo, Robert A.
  • Paterson, David L.
  • Pascual, Álvaro
  • Rodríguez-Baño, Jesús
[Background] Bloodstream infections (BSIs) due to ESBL-producing Enterobacteriaceae (ESBL-E) are frequent yet outcome prediction rules for clinical use have not been developed. The objective was to define and validate a predictive risk score for 30 day mortality., [Methods] A multinational retrospective cohort study including consecutive episodes of BSI due to ESBL-E was performed; cases were randomly assigned to a derivation cohort (DC) or a validation cohort (VC). The main outcome variable was all-cause 30 day mortality. A predictive score was developed using logistic regression coefficients for the DC, then tested in the VC., [Results] The DC and VC included 622 and 328 episodes, respectively. The final multivariate logistic regression model for mortality in the DC included age >50 years (OR = 2.63; 95% CI: 1.18–5.85; 3 points), infection due to Klebsiella spp. (OR = 2.08; 95% CI: 1.21–3.58; 2 points), source other than urinary tract (OR = 3.6; 95% CI: 2.02–6.44; 3 points), fatal underlying disease (OR = 3.91; 95% CI: 2.24–6.80; 4 points), Pitt score >3 (OR = 3.04; 95 CI: 1.69–5.47; 3 points), severe sepsis or septic shock at presentation (OR = 4.8; 95% CI: 2.72–8.46; 4 points) and inappropriate early targeted therapy (OR = 2.47; 95% CI: 1.58–4.63; 2 points). The score showed an area under the receiver operating curve (AUROC) of 0.85 in the DC and 0.82 in the VC. Mortality rates for patients with scores of < 11 and ≥11 were 5.6% and 45.9%, respectively, in the DC, and 5.4% and 34.8% in the VC., [Conclusions] We developed and validated an easy-to-collect predictive scoring model for all-cause 30 day mortality useful for identifying patients at high and low risk of mortality., This study was funded by: the Ministerio de Economía y Competitividad, Instituto de Salud Carlos III co-financed by the European Development Regional Fund ‘A way to achieve Europe’ ERDF, the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015), FIS grant PI10/02021 and FIS grant PI14/01832. B. G. G., J. R. B., A. P. and Y. C. also received funds from the COMBACTE-CARE project, Innovative Medicines Initiative (IMI), the European Union’s Seventh Framework Programme (FP7/2007-2013) and in-kind contributions from EFPIA companies. R. A. B. was also supported in part by funds and/or facilities provided by the Cleveland Department of Veterans Affairs, the Veterans Affairs Merit Review Program and the Geriatric Research Education and Clinical Center VISN 10 (VISN 10 GRECC), and the NIAID of the NIH under award numbers R01AI072219 and R01AI063517., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Oral decontamination with aminoglycosides is associated with lower risk of mortality and infections in high-risk patients colonized with colistin-resistant, KPC-producing Klebsiella pneumoniae

  • Machuca, Isabel
  • Gutiérrez-Gutiérrez, Belén
  • Pérez-Cortés, Salvador
  • Gracia-Ahufinger, Irene
  • Serrano-López, Josefina
  • Madrigal, María Dolores
  • Barcala, José
  • Rodríguez-López, Fernando
  • Rodríguez-Baño, Jesús
  • Torre-Cisneros, Julián
[Objectives] Invasive infections caused by KPC-producing Klebsiella pneumoniae (KPCKP) are associated with very high mortality. Because infection is usually preceded by rectal colonization, we investigated if decolonization therapy (DT) with aminoglycosides had a protective effect in selected patients., [Methods] Patients with rectal colonization by colistin-resistant KPCKP who were at high risk of developing infection (because of neutropenia, surgery, previous recurrent KPCKP infections or multiple comorbidities) were followed for 180 days. Cox regression analysis including a propensity score was used to investigate the impact of the use of two intestinal decolonization regimens with oral aminoglycosides (gentamicin and neomycin/streptomycin) on mortality, risk of KPCKP infections and microbiological success. The study was registered with ClinicalTrials.gov (NCT02604849)., [Results] The study sample comprised 77 colonized patients, of which 44 (57.1%) received DT. At 180 days of follow-up, decolonization was associated with a lower risk of mortality in multivariate analyses (HR 0.18; 95% CI 0.06–0.55) and a lower risk of KPCKP infections (HR 0.14; 95% CI 0.02–0.83) and increased microbiological success (HR 4.06; 95% CI 1.06–15.6). Specifically, gentamicin oral therapy was associated with a lower risk of crude mortality (HR 0.15; 95% CI 0.04–0.54), a lower risk of KPCKP infections (HR 0.86; 95% CI 0.008–0.94) and increased microbiological response at 180 days of follow-up (HR 5.67; 95% CI 1.33–24.1). Neomycin/streptomycin therapy was only associated with a lower risk of crude mortality (HR 0.22; 95% CI 0.06–0.9)., [Conclusions] Intestinal decolonization with aminoglycosides is associated with a reduction in crude mortality and KPCKP infections at 180 days after initiating treatment., Funded by the Ministerio de Economía y Competitividad, Instituto de Salud Carlos III—co-financed by the European Development Regional Fund ‘A way to achieve Europe’ ERDF, the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015). We also received funding from COMBACTE-CARE (Combatting bacterial resistance in Europe—Carbapenem resistance), the Innovatives Medicine Initiative (IMI), the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies′ in-kind contribution (call IMI 9th), Grant agreement 115620., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Intravenous fosfomycin—back to the future. Systematic review and meta-analysis of the clinical literature

  • Grabein, B.
  • Graninger, W.
  • Rodríguez-Baño, Jesús
  • Dinh, A.
  • Liesenfeld, D. B.
[Objectives] We conducted a systematic review and meta-analysis to summarize the clinical evidence and usage patterns of intravenous fosfomycin from its development to the present time., [Methods] PubMed, the Cochrane Library and local journals were searched for relevant studies reporting aggregated data of intravenous fosfomycin use in adults and children, with no restrictions regarding study design. Single case reports were excluded. Data were systematically abstracted for all included studies. Clinical and microbiological efficacy from randomized controlled and comparative observational studies were synthesized using meta-analysis to calculate pooled effect sizes., [Results] In all, 128 studies on intravenous fosfomycin in 5527 patients were evaluated. Fosfomycin was predominantly used for sepsis/bacteraemia, urinary tract, respiratory tract, bone and joint, and central nervous system infections. No difference in clinical (OR 1.44, 95% CI 0.96–2.15) or microbiological (OR 1.28, 95% CI 0.82–2.01) efficacy between fosfomycin and other antibiotics was observed in comparative trials. The pooled estimate for resistance development during fosfomycin monotherapy was 3.4% (95% CI 1.8%–5.1%). Fosfomycin showed a favourable safety profile, with generally mild adverse events not requiring discontinuation of treatment. Included studies explored intravenous fosfomycin as an anti-staphylococcal agent in monotherapy and combination therapy, whereas studies from 1990 focused on combination therapy (fosfoymcin + β-lactams or aminoglycosides) for challenging infections frequently caused by multidrug-resistant organisms., [Conclusion] Intravenous fosfomycin can play a vital role in the antibiotic armamentarium, given its long history of effective and safe use. However, well-designed randomized controlled trials are still desired., All authors approved the final version of the manuscript. JRB receives funding for research from the Ministerio de Economía y Competitividad, Instituto de Salud Carlos III—co-financed by European Development Regional Fund “A way to achieve Europe” ERDF, Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015), FIS (PI 13/01282), and the Innovative Medicines Initiative (European Union and EFPIA partners in kind; agreements 115523 COMBACTE-NET, 115620 COMBACTE-CARE and 115737 COMBACTE-MAGNET projects).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition

  • Harris, Patrick N.A.
  • McNamara, J. F.
  • Lye, D. C.
  • Davis, J. S.
  • Bernard, Louis
  • Cheng, A. C.
  • Doi, Y.
  • Fowler, Vance G.
  • Kaye, K. S.
  • Leibovici, Leonard
  • Lipman, Jeffrey
  • Llewelyn, Martin J.
  • Muñoz-Price, S.
  • Paul, Mical
  • Peleg, A. Y.
  • Rodríguez-Baño, Jesús
  • Rogers, B. A.
  • Seifert, Harald
  • Thamlikitkul, V.
  • Thwaites, Guy
  • Tong, S. Y. C.
  • Turnidge, J.
  • Utili, R.
  • Webb, S. A. R.
  • Paterson, David L.
[Objectives] To define standardized endpoints to aid the design of trials that compare antibiotic therapies for bloodstream infections (BSI)., [Methods] Prospective studies, randomized trials or registered protocols comparing antibiotic therapies for BSI, published from 2005 to 2016, were reviewed. Consensus endpoints for BSI studies were defined using a modified Delphi process., [Results] Different primary and secondary endpoints were defined for pilot (small-scale studies designed to evaluate protocol design, feasibility and implementation) and definitive trials (larger-scale studies designed to test hypotheses and influence clinical practice), as well as for Staphylococcus aureus and Gram-negative BSI. For pilot studies of S. aureus BSI, a primary outcome of success at day 7 was defined by: survival, resolution of fever, stable/improved Sequential Organ Failure Assessment (SOFA) score and clearance of blood cultures, with no microbiologically confirmed failure up to 90 days. For definitive S. aureus BSI studies, a primary outcome of success at 90 days was defined by survival and no microbiologically confirmed failure. For pilot studies of Gram-negative BSI, a primary outcome of success at day 7 was defined by: survival, resolution of fever and symptoms related to BSI source, stable or improved SOFA score and negative blood cultures. For definitive Gram-negative BSI studies, a primary outcome of survival at 90 days supported by a secondary outcome of success at day 7 (as previously defined) was agreed., [Conclusions] These endpoints provide a framework to aid future trial design. Further work will be required to validate these endpoints with respect to patient-centred clinical outcomes., PH is supported by an Australian Postgraduate Award from the University of Queensland. VGF was supported by R01AI068804 from National Institutes of Health. KSK is supported by the National Institute of Allergy and Infectious Diseases (NIAID), DMID Protocol no. 10-0065 and R01AI119446. ACC and AYP were supported by an Australian National Health and Medical Research Council Career Development Fellowship. HS receives funding from the German Centre for Infection Research (DZIF), Germany. JRB receives funding for research from Ministerio de Economía y Competitividad, Instituto de Salud Carlos III—co-financed by European Development Regional Fund ‘A way to achieve Europe' ERDF, Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015). JRB and MP receive funding from Innovatives Medicine Initiative (IMI), European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies (COMBACTE, COMBACTE-CARE and COMBACTE-MAGNET projects, grant agreements 1155223, 115620 and 115737). RU and MP are supported by the European Union 7th Framework Programme (Project ‘AIDA’). SYCT is supported by an NHMRC Career Development Fellowship 1065736. JT received funding from NHMRC (Project Grant ID 1044941).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae

  • Ballestero-Téllez, Mónica
  • Docobo-Pérez, Fernando
  • Rodríguez-Martínez, José-Manuel
  • Conejo, M. Carmen
  • Ramos-Guelfo, M. S.
  • Blázquez Gómez, Jesús
  • Rodríguez-Baño, Jesús
  • Pascual Bravo, Alberto
[Objectives] Fosfomycin is re-evaluated as a treatment of multidrug-resistant Enterobacteriaceae infections. However, MIC differences have been described among the different susceptibility testing. The aim was to study the role of the different inoculum size used in agar dilution with respect to broth microdilution, according to CLSI, in the fosfomycin MIC discrepancies., [Methods] Fosfomycin MICs were determined using agar dilution (reference) and broth microdilution in 220 Escherichia coli (n = 81) and Klebsiella pneumoniae (n = 139) clinical isolates. Fosfomycin mutant frequencies were determined in 21 E. coli (MIC = 1 mg/L) and 21 K. pneumoniae (MIC = 16 mg/L). The emergence of resistant subpopulations of five E. coli strains (MIC = 1 mg/L) was monitored over the time by microdilution assay using 0, 4 and 8 mg/L of fosfomycin, and eight different inocula (5 × 105−3.91 × 103 CFU/well, 1 : 2 dilutions)., [Results] For E. coli, 86.4% of categorical agreement (CA), 9.1% very major errors (VME), 3.3% major errors (ME) and 9.9% minor errors (mE) were found. For K. pneumoniae, CA was 51.1%, VME 15.7%, ME 28.4% and mE 25.2%. Essential agreement (±1–log2) was observed in 55.45%. By microdilution, 35.9% of the MICs showed discrepancies of ≥2 dilutions. Initial inoculum used was 5.63 times higher in the microdilution method, in range with CLSI methodology for both techniques. Fosfomycin mutant frequencies were 6.05 × 10–5 (4 × MIC) to 5.59 × 10–7 (256 × MIC) for E. coli, and 1.49 × 10–4 (4 × MIC) to 1.58 × 10–5 (16 × MIC) for K. pneumoniae. Resistant subpopulations arose mainly after 8 h of incubation with inocula >3.13 × 104 CFU/well., [Conclusions] The higher inoculum used in the microdilution method enriched the initial inoculum with resistant subpopulations and could partially explain the fosfomycin MIC discrepancies with respect to the agar dilution method., This work was supported by the Ministerio de Economía y Competitividad, Instituto de Salud Carlos III (PI13/01885 and PI13/01282) and the Consejería de Salud, Junta de Andalucía (PI-0044-2013), Spain. It was partially supported by Plan Nacional de I+D+i and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD12/0015)—co-financed by European Development Regional Fund ‘A way to achieve Europe’ ERDF. Fernando Docobo-Pérez is supported by a VPPI-US fellowship from the University of Sevilla. JRB acts as scientific advisor for AstraZeneca, Merck and Achaogen, and was speaker for AstraZeneca, Merck, Pfizer and Astellas. He received funding for research from 115523 COMBACTE-NET, 115620 COMBACTE-CARE, and 115737 COMBACTE-MAGNET projects, Innovative Medicines Initiative (IMI), funded by the European Union and EFPIA companies.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The microbial contribution to the trophic position of stomiiform fishes

  • Bode, Antonio
  • Olivar, M. Pilar
  • López-Pérez, Cristina
  • Hernández León, Santiago
9 pages, 3 figures, 1 table, supplementary data https://doi.org/10.1093/icesjms/fsab189.-- Data availability statement: The original data on sample location, individual fish characteristics and stable isotope composition, including amino acids, can be accessed through the PANGAEA repository (Bode et al., 2021b). Similarly, the original data for copepods can be found in Bode et al. (2018b), The trophic position (TP) of fishes determines their importance in terms of energy flows within food webs. However, accurate estimations of TP are often prevented because of the difficulties in tracing all food sources. This is particularly challenging for omnivorous fishes, such as those from the Order Stomiiformes. In this study, we applied recent developments in stable isotope analysis of amino acids to untangle the contributions of microbial vs. metazoan food webs in 13 species of Stomiiformes. The inclusion of the microbial food web reduced the differences between TP estimates using stable isotopes and those derived from stomach content analysis. In addition, the new estimates allowed to quantify the relative contribution of the microbial food web to each species (6–21%), highlighting the importance of detritus consumption even in piscivorous species (e.g. Stomias boa and Chauliodus danae). The comparison of TP estimates obtained with selected amino acids in fish muscle allowed for the detection of the microbial influence integrated at time scales relevant for net fish growth, even when trophic exchanges in the microbial food web occur at much shorter time scales. The assessment of TP considering the differential contribution of microbial and metazoan food webs challenges our current understanding of marine food webs; yet provides a new quantitative tool for the analysis of their structure and function, This research was funded by projects MAFIA (CTM2012-39587-C04), BATHYPELAGIC (CTM2016-78853-R), and QLOCKS (PID2020-115620RB-100) from the Plan Estatal de I+D+I (Spain), projects SUMMER (grant agreement number 817806) and TRIATLAS (grant agreement number 817578), from the European Union (Horizon 2020 Research and Innovation Programme), and the support through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000928-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Household acquisition and transmission of extended-spectrum β-lactamase (ESBL) -producing Enterobacteriaceae after hospital discharge of ESBL-positive index patients

  • Riccio, María E.
  • Verschuuren, Tess
  • Conzelmann, Nadine
  • Martak, Daniel
  • Meunier, Alexandre
  • Salamanca, Elena
  • Delgado-Valverde, Mercedes
  • Guther, Julia
  • Peter, Silke
  • Paganini, Julian
  • Martischang, Romain
  • Sauser, Julien
  • Kraker, Marlieke de
  • Cherkaoui, Abdessalam
  • Fluit, Ad C.
  • Cooper, Ben S.
  • Hocquet, Didier
  • Kluytmans, Jan
  • Tacconelli, Evelina
  • Rodríguez-Baño, Jesús
  • Harbarth, Stephan
MODERN WP2 study group: Caroline Brossier, Elodie von Dach, Gesuele Renzi, Jacques Schrenzel, Stefanie Bunk, Siri Goepel, Florian Hölzl, Michael Eib, Ingo B.Autenrieth, Álvaro Pascual, Xavier Bertrand, Jelle Scharringa, Patrick Musicha., [Objectives] This study aimed to determine rates and risk factors of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE) acquisition and transmission within households after hospital discharge of an ESBL-PE-positive index patient., [Methods] Two-year prospective cohort study in five European cities. Patients colonized with ESBL-producing Escherichia coli (ESBL-Ec) or Klebsiella pneumoniae (ESBL-Kp), and their household contacts were followed up for 4 months after hospital discharge of the index case. At each follow up, participants provided a faecal sample and personal information. ESBL-PE whole-genome sequences were compared using pairwise single nucleotide polymorphism-based analysis., [Results] We enrolled 71 index patients carrying ESBL-Ec (n = 45), ESBL-Kp (n = 20) or both (n = 6), and 102 household contacts. The incidence of any ESBL-PE acquisition among household members initially free of ESBL-PE was 1.9/100 participant-weeks at risk. Nineteen clonally related household transmissions occurred (case to contact: 13; contact to case: 6), with an overall rate of 1.18 transmissions/100 participant-weeks at risk. Most of the acquisition and transmission events occurred within the first 2 months after discharge. The rate of ESBL-Kp household transmission (1.16/100 participant-weeks) was higher than of ESBL-Ec (0.93/100 participant-weeks), whereas more acquisitions were noted for ESBL-Ec (1.06/100 participant-weeks) compared with ESBL-Kp (0.65/100 participant-weeks). Providing assistance for urinary and faecal excretion to the index case by household members increased the risk of ESBL-PE transmission (adjusted prevalence ratio 4.3; 95% CI 1.3–14.1)., [Conclusions] ESBL-PE cases discharged from the hospital are an important source of ESBL-PE transmission within households. Most acquisition and transmission events occurred during the first 2 months after hospital discharge and were causally related to care activities at home, highlighting the importance of hygiene measures in community settings., [Clinical study registration] German Clinical Trials Register, DRKS-ID: DRKS00013250., This study was part of a Joint Programming Initiative on Antimicrobial Resistance collaborative research project, under the 2016 Joint Call framework (Transnational Research Projects on the Transmission Dynamics of Antibacterial Resistance). It received funding from the following national research agencies: Instituto de Salud Carlos III (grant no. AC16/00076), Netherlands Organization for Health Research and Development (grant no. AC681055), Swiss National Science Foundation (grant no. 40AR40-173608), German Federal Ministry of Education and Research (grant no. 01KI1830) and Agence Nationale de la Recherche (grant no. ANR-16-JPEC-0007-03). As part of a separate research project, Marlieke de Kraker has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement nos 115523, 115620 and 115737 (Combatting Bacterial Resistance in Europe projects (COMBACTE)), resources of which are composed of financial contribution from the European Union's 7th Framework Programme (FP7/2007±2013) and the European Federation of Pharmaceutical Industries and associations companies' in-kind contribution. Also, Elena Salamanca, Mercedes Delgado and Jesús Rodríguez-Baño received support for research from by the Plan Nacional de I+D+i 2013-2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Ciencia, Innovación y Universidades, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001), co-financed by the European Development Regional Fund ‘A way to achieve Europe’, Operative Programme Intelligence Growth 2014-2020., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

PRAISE: providing a roadmap for automated infection surveillance in Europe

  • van Mourik, Maaike S.M.
  • van Rooden, Stephanie M.
  • Abbas, Mohamed
  • Aspevall, Olov
  • Astagneau, Pascal
  • Bonten, Marc J. M.
  • Carrara, Elena
  • Gomila-Grange, Aina
  • de Greeff, Sabine C.
  • Gubbels, Sophie
  • Harrison, Wendy
  • Humphreys, Hilary
  • Johansson, Andres
  • Koek, Mayke B.G.
  • Kristensen, Brian
  • Lepape, Alain
  • Lucet, Jean-Christophe
  • Mookerjee, Siddharth
  • Naucler, Pontus
  • Palacios-Baena, Zaira Raquel
  • Presterl, Elisabeth
  • Pujol, Miquel
  • Reilly, Jacqui
  • Roberts, Christopher
  • Tacconelli, Evelina
  • Teixeira, Daniel
  • Tängdén, Thomas
  • Karlsson Valik, John
  • Behnke, Michael
  • Gastmeier, Petra
[Introduction] Healthcare-associated infections (HAI) are among the most common adverse events of medical care. Surveillance of HAI is a key component of successful infection prevention programmes. Conventional surveillance – manual chart review – is resource intensive and limited by concerns regarding interrater reliability. This has led to the development and use of automated surveillance (AS). Many AS systems are the product of in-house development efforts and heterogeneous in their design and methods. With this roadmap, the PRAISE network aims to provide guidance on how to move AS from the research setting to large-scale implementation, and how to ensure the delivery of surveillance data that are uniform and useful for improvement of quality of care., [Methods] The PRAISE network brings together 30 experts from ten European countries. This roadmap is based on the outcome of two workshops, teleconference meetings and review by an independent panel of international experts., [Results] This roadmap focuses on the surveillance of HAI within networks of healthcare facilities for the purpose of comparison, prevention and quality improvement initiatives. The roadmap does the following: discusses the selection of surveillance targets, different organizational and methodologic approaches and their advantages, disadvantages and risks; defines key performance requirements of AS systems and suggestions for their design; provides guidance on successful implementation and maintenance; and discusses areas of future research and training requirements for the infection prevention and related disciplines. The roadmap is supported by accompanying documents regarding the governance and information technology aspects of implementing AS., [Conclusions] Large-scale implementation of AS requires guidance and coordination within and across surveillance networks. Transitions to large-scale AS entail redevelopment of surveillance methods and their interpretation, intensive dialogue with stakeholders and the investment of considerable resources. This roadmap can be used to guide future steps towards implementation, including designing solutions for AS and practical guidance checklists., This network has been supported under the 7th transnational call within the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), Network Call on Surveillance (2018) and was thereby funded by ZonMw (grant 549007001). This project also received support from the COMBACTE MAGNET EPI-Net project funded by the Innovative Medicines Initiative Joint Undertaking under grant agreement 115523 | 115620 | 115737 | 777362, resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution. J.K.V. was supported by grants from Region Stockholm and Vinnova. H.H. reports grants from Pfizer and Astellas as well as personal fees from Pfizer outside the submitted work., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Trophic position of dolphins tracks recent changes in the pelagic ecosystem of the Macaronesian region (NE Atlantic)

  • Bode, Antonio
  • Saavedra, Camilo
  • Álvarez González, Miguel
  • Arregui, Marina
  • Arbelo, Manuel
  • Fernández, Antonio
  • Freitas, Luis
  • Silva, Mónica A.
  • Prieto, Rui
  • Azevedo, José M. N.
  • Giménez, Joan
  • Pierce, Graham J.
  • Santos, María Begoña
14 pages, 6 figures, 1 table.-- Open access, Dolphins play a key role in marine food webs as predators of mid-trophic-level consumers. Because of their mobility and relatively long life span, they can be used as indicators oflarge-scale changes in the ecosystem. In this study, we calculated the trophic position (TP) of 5 dolphin species from the Canary, Madeira and Azores Islands using bulk and compound-specific stable isotope ratios from muscle tissue to assess trophic adaptations to recent changes in the availability of feeding resources. Dolphin TP values were then compared with those of 7 other species of cetaceans from this region. Analysis of stable nitrogen isotopes in amino acids of the common dolphin indicated non-significant effects of changes in the basal resources of the food web and thus supported the use of bulk samples for TP estimations. Dolphins occupied an intermediate TP (mean: 3.91 to 4.20) between fin (3.25) and sperm whales (4.95). Species-specific TP were equivalent among islands. However, TP increased for the common dolphin and decreased for the bottlenose dolphin (the latter also becoming more oceanic) between 2000 and 2018 in the Canary Islands. These results suggest different impacts of recent changes in the oceanography and in the pelagic food web of the Macaronesian region on the trophic ecology of dolphin species, This study was supported in part by the projects QLOCKS (PID2020-115620RB-I00), funded by MCIN/AEI/10.13039/501100011033 (Spain), MISTIC SEAS 2 (‘Applyinga subregional coherent and coordinated approach to the monitoring and assessment of marine biodiversity in Macaronesia for the second cycle of the MSFD’), funded by the Directorate General Environment of the European Commission (Grant Agreement No. 11.0661/2017/750679/SUB/ENV.C2), MISTIC SEAS 3 (‘Developing a coordinated approach for assessing Descriptor 4 via its linkages with D1 and other relevant descriptors in the Macaronesian subregion’), funded by the Directorate General Environment of the European Commission (Grant Agreement No. 110661/2018/794676/SUB/ENV.C2), RACAM (Rede de Arrojamentos de Cetáceos do Arquipélago da Madeira), implemented by the Madeira Whale Museum and funded by the Machico Municipality and projects MARCET (MAC/1.1b/149) and MARCET II (MAC/2.6c/392), both co-financed by EU Programme INTERREG MAC 2014−2020, and through the Commission (28-5307) for ‘Technical scientific advice for the protection of the marine environment: assessment and monitoring of marine strategies, monitoring of marine protected areas of state competence (2018−2021)’ of the Spanish Ministry of Economy and Competitiveness Demographic Challenge (MITECO). Data collection in the Azores was supported by FCT and FRCT through TRACE-PTDC/MAR/74071/2006, MAPCET-M2.1.2/F/012/2011, IF/00943/2013/CP1199/CT0001 (FEDER, COMPETE, QREN, POPH, ESF, Portuguese Ministry for Science and Education, Azores 2020 Operational Programme). M.A.S. was funded by SUMMEREU-H2020 GA 817806. M.A.S. and R.P. were funded by OP AZORES 2020, through the EU Fund 01-0145-FEDER-000140. Okeanos is funded by FCT (UIDB/05634/2020) and by the Regional Government of the Azores (M1.1.A/REEQ.CIENTÍFICO UI&D/2021/010). J.G. was supported by the Spanish National Programme Juan de la Cierva-Formación (MCIN/AEI/10.13039/501100011033 FJC2019-040016-I). This work acknowledges the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000928-S) to the Institute of Marine Science (ICM-CSIC), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Use of Formalin-Preserved Collections to Infer Trophic Indicators of Marine Zooplankton from Stable Isotopes

  • Bode, Antonio
  • Otero, Jaime
  • Lamas, Ángel F.
  • Mompeán, Carmen
Formalin preservation affects the stable isotope composition of zooplankton samples, thus limiting the analysis of valuable collections covering large time intervals. Here, we compare different procedures for correcting the bias caused by formalin in δ13C and δ15N of zooplankton community samples. Zooplankton samples representative of seasonal variations in the period 2000–2009 were collected off A Coruña (NW Spain). Part of the sample was immediately dried and analysed for δ13C, δ15N, and elemental composition within 3 years of collection. These values were used as the unpreserved reference. The remaining sample was preserved in 4% formaldehyde and aliquots obtained after a period ranging from 3 years to more than 10 years of storage were analysed as the originally dried samples. Additionally, the copepod fraction of total biomass was determined in the preserved samples. Corrections of formalin effects based on ordinary least squares regression had large uncertainties, while mass balance corrections based on the change in C:N ratio (only possible for δ13C) overestimated reference values. However, either simple corrections based on the mean difference between values in dry and preserved samples or more complex generalised additive models considering seasonality, copepod biomass, and time of sample storage, produced estimations with relatively low uncertainty. Our results highlight the importance of determining specific correction solutions for each preserved collection before reconstructing stable isotope time series. Furthermore, the uncertainties associated with the estimates can be used in sensitivity analysis to assess their potential impact on the interpretation of the series., This research was funded by projects QLOCKS (PID2020-115620RB-100, MCIN/AEI/10.13039/501100011033) and RADIALES (Instituto Español de Oceanografía, Spain). C.M. was supported by a FPI fellowship from the Instituto Español de Oceanografía (Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Using MixSIAR to quantify mixed contributions of primary producers from amino acid δ15N of marine consumers

  • García Seoane, Rita
  • Viana, Inés G.
  • Bode, Antonio
Estimations of the trophic position and the food web nitrogen baseline from compound-specific isotope analysis of individual amino acids (CSIA-AA) are challenged when the diet of consumer organisms relies on different proportions of vascular and non-vascular primary producers. Here we propose a method to infer such proportions using mixing models and the ¿15N CSIA-AA values from marine herbivores. Combining published and new data, we first characterized CSIA-AA values in phytoplankton, macroalgae and vascular plants, and determined their characteristic ß values (i.e. the isotopic difference between trophic and source AA). Then, we applied MixSIAR Bayesian isotope mixing models to investigate the transfer of these isotopic signals to marine herbivores (molluscs, green turtles, zooplankton and fish), and their utility to quantify autotrophic sources. We demonstrated that primary producer groups have distinct ¿15NAA fingerprints that can be tracked into their primary consumers, thus offering a rapid solution to quantify resource utilization and estimate ßmix values in mixed-sourced environments., This research was partially supported by projects ANILE (CTM2009-08396), from Plan Nacional de I + D + i (Spain), and QLOCKS (PID2020-115620RB-100), from MCIN/AEI/10.1303/5011000110339/ (Spain). R. García-Seoane was supported by a postdoctoral research grant Juan de la Cierva-Formación (FJC2019-040921-I), from MCIN/AEI/10.13039/501100011033 (Spain) and EU NextGenerationEU/PRTR programmes, and I. G. Viana was supported by a postdoctoral research grant Juan de la Cierva-Incorporación (IJC2019-040554-I), from MCIN/AEI/10.13039/501100011033 (Spain). We thank Jens M. Nielsen for his valuable comments on a preliminary version of this manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Seasonal upwelling influence on trophic indices of mesozooplankton in a coastal food web estimated from δ15N in amino acids

  • García-Seoane, Rita
  • Viana, Inés G.
  • Bode, Antonio
Mesozooplankton communities in upwelling ecosystems are known to be influenced by seasonal upwelling enhancing primary productivity. However, the extent to which changes in trophic dynamics of mesozooplankton are driven by variations in the baseline of nitrogen or in the trophic position (TP) is poorly understood. We used nitrogen stable isotopes (δN) in bulk and in specific amino acids (CSIA-AA), as well as the taxonomic composition of mesozooplankton samples collected monthly during two full years, to investigate whether the upwelling intensity affects the isotopic N baseline and other trophic indices at the community level in the coastal system off NW Iberian Peninsula. We hypothesized that enhanced phytoplankton productivity during upwelling events would lead to a shorter and more efficient food web. Upwelling induced mesozooplankton herbivory (by increasing the abundance and biomass of omnivorous-herbivorous copepods and other taxa), resulting in a linear decrease of TP (estimated using Glx = glutamic acid + glutamine, which mainly involves metazoan links) from downwelling to upwelling situations. In contrast, TP (estimated using alanine, which also reflects microbial trophic pathways) was highest in low-moderate upwelling and decreased with upwelling strength. Thus, an optimal coupling between metazoan and microbial food webs was reached at low-moderate upwelling intensities when the microbial contribution was ca. 25 %, while this contribution decreased (<15 %) either during downwelling or during strong upwelling. However, the significance of differences in mean values of TP and zooplankton composition was small due to the rapid succession of upwelling and downwelling events. Our results illustrate how a combination of CSIA-AA and community data can provide valuable information on rapid changes in mesozooplankton food web structure in highly dynamic upwelling systems., This research was partially supported by projects ANILE (CTM2009-08396), from Plan Nacional de I+D+i (Spain), and QLOCKS (PID2020-115620RB-100), from MCIN/AEI/10.13039/501100011033 (Spain). R. García-Seoane was supported by a postdoctoral research grant Juan de la Cierva-Formación (FJC2019-040921-I), from MCIN/AEI/10.13039/501100011033 (Spain) and EU NextGenerationEU/PRTR programmes, and I. G. Viana was supported by a postdoctoral research grant Juan de la Cierva-Incorporación (IJC2019-040554-I), from MCIN/AEI/10.13039/501100011033 (Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synchronized multidecadal trends and regime shifts in North Atlantic plankton populations

  • Bode, Antonio
Recent changes in oceanic plankton are being reported at unprecedented rates. Most changes are related to environmental factors, and many were identified as driven by climate, either through natural cycles or by anthropogenic effects. However, the separation of both effects is difficult because of the short length of most observational series. Moreover, some changes are related to trends and cycles, while others were perceived as system shifts, often synchronized over large spatial scales. Here, studies on observational series of plankton, with the focus in the North Atlantic, are reviewed. Two main periods of shifts in plankton assemblages were identified: one in the late 1980s and a more recent one at the beginning of the new millennium. While the origin and extent of most shifts varied locally, their synchronization seems to confirm the response of plankton to changes in warming and in large-scale climatic factors. Changes in species abundance and distribution patterns were generally related to hydrographic factors, but also to non-linear effects of warming, the latter particularly affecting species in regions near the limits of their thermal niches. Indeed, most of the changes were attributed to trade-offs between different biological strategies. Taken together, the reviewed case studies indicate a lagged biological response to variations in the local environment driven by large-scale climate forcing. The challenges for interpreting future shifts include considering local changes within a larger geographical area, variations in species life traits, and potential top-down effects of plankton predators., I acknowledge the support of projects RADIALES (IEO-CSIC, Spain) and QLOCKS (PID2020-115620RB-100), funded by MCIN/AEI/10.13039/501100011033, Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A missing trophic link: Contribution of the microbial loop to the estimation of the trophic position of pelagic consumers

  • Viana, Inés G.
  • García-Seoane, Rita
  • Bode, Antonio
Trophic position estimation has been a central issue in food web studies. Estimates using compound-specific isotopic analyses of amino acids were generally based on the trophic enrichment of glutamic acid. However, this trophic position estimation mainly accounts for the trophic steps involving metazoa, as the isotopic fractionation of this amino acid is minimal at trophic steps within the microbial food web. Alternatively, trophic position estimates based on alanine seem to also reflect microbial trophic steps. The difference between these estimations can provide an index of the microbial food web contribution to the trophic position of a particular consumer. Here, we examined the differences between both trophic position estimates through a meta-analysis of the published data over a large range of marine consumers. The results suggest that the microbial contribution to trophic position decreases as trophic position increases in the marine pelagic food web, showing the lowest values in top consumers. Ureotelic organisms showed the highest microbial contributions. The current data point to an upper limit for the estimation of this index at δ15N values of glutamic acid or alanine of ~ 18.5‰, or trophic positions of 3.9 or 4.7 for fish and ammoniotelic organisms, respectively. Under the stable isotope lens, bacteria and protists may play a key role in the estimation of trophic positions of consumers. However, uncertainties that related both to the microbial loop (e.g., metabolic bacterial pathways) and to metazoan consumers (e.g., influence of the gut microbiome) still obscure the establishment of clear quantitative links between microbial and metazoan food webs., This research was supported by MCIN/AEI/10.13039/501100011033 (Spain) through project QLOCKS (PID2020-115620RB-100), postdoctoral research grants Juan de la Cierva-Incorporación to I.G.V. (IJC2019-040554-I), and Juan de la Cierva-Formación to R.G.S. (FJC2019-040921-I). R.G.S also received funds from the EU NextGenerationEU/PRTR programme. We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its unit of Information Resources for Research (URICI)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

International and regional spread of carbapenem-resistant Klebsiella pneumoniae in Europe

  • Budia-Silva, Mabel
  • Kostyanev, Tomislav
  • Ayala-Montaño, Stefany
  • Bravo-Ferrer, José
  • García-Castillo, María
  • Cantón, Rafael
  • Goossens, Herman
  • Rodríguez-Baño, Jesús
  • Grundmann, Hajo
  • Reuter, Sandra
Carbapenem-resistant Klebsiella pneumoniae (CRKP) are of particular concern due to the spread of antibiotic resistance genes associated with mobile genetic elements. In this study, we collected 687 carbapenem-resistant strains recovered among clinical samples from 41 hospitals in nine Southern European countries (2016-2018). We identified 11 major clonal lineages, with most isolates belonging to the high-risk clones ST258/512, ST101, ST11, and ST307. blaKPC-like was the most prevalent carbapenemase-encoding gene (46%), with blaOXA-48 present in 39% of isolates. Through the combination and comparison of this EURECA collection with the previous EuSCAPE collection (2013-2014), we investigated the spread of high-risk clones circulating in Europe exhibiting regional differences. We particularly found blaKPC-like ST258/512 in Greece, Italy, and Spain, blaOXA-48 ST101 in Serbia and Romania, blaNDM ST11 in Greece, and blaOXA-48-like ST14 in Türkiye. Genomic surveillance across Europe thus provides crucial insights for local risk mapping and informs necessary adaptions for implementation of control strategies., This research was funded by: Innovative Medicines Initiative Joint Undertaking (https://www.imi.europa.eu/) under Grant Agreement Nos. 115523 [COMBACTE-NET (Combatting Bacterial Resistance in Europe)] and 115620 (COMBACTE-CARE) to TK, JBF-A, MG-C, RC, HGo, JR-B, and HGr; Plan Nacional de I+D+I, Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Ciencia, Innovación y Universidades, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0001 and RD16/0016/0011) and CIBERINFEC (21/13/00012, 21/13/00084) to JR-B and RC; JPI-AMR call (K-STaR 01KI1910) to HGr and SR; Federal Ministry of Education and Research (BMBF; TAPIR 01KI2018) to SR. Open Access funding enabled and organized by Projekt DEAL., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Aztreonam-avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial

  • Carmeli, Yehuda
  • Cisneros, José Miguel
  • Paul, Mical
  • Daikos, George L.
  • Wang, Minggui
  • Torre-Cisneros, Julian
  • Singer, George
  • Titov, Ivan
  • Gumenchuk, Illia
  • Zhao, Yongjie
  • Jiménez-Rodríguez, Rosa-María
  • Liang, Lu
  • Chen, Gang
  • Pyptiuk, Oleksandr
  • Aksoy, Firdevs
  • Rogers, Halley
  • Wible, Michele
  • Arhin, Francis F.
  • Luckey, Alison
  • Leaney, Joanne L.
  • Pypstra, Rienk
  • Chow, Joseph W.
Upon request, and subject to certain criteria, conditions, and exceptions, Pfizer will provide access to individual de-identified participant data from Pfizer-sponsored global interventional clinical studies conducted for medicines, vaccines, and medical devices first, for indications that have been approved in the USA, EU, or both and second, in programmes that have been terminated (ie, development for all indications has been discontinued). Pfizer will also consider requests for the protocol, data dictionary, and statistical analysis plan. Data may be requested from Pfizer trials 24 months after study completion. For more information see Pfizer's clinical trial data information., There is a need for additional therapeutic options for serious infections caused by Gram-negative pathogens. In the phase 3, descriptive REVISIT study, we investigated the safety and efficacy of aztreonam-avibactam in the treatment of complicated intra-abdominal infections or hospital-acquired pneumonia or ventilator-associated pneumonia (HAP-VAP) caused, or suspected to be caused, by Gram-negative bacteria., This study was sponsored by Pfizer and was supported in whole or in part with federal funds from the US Department of Health and Human Services; Administration for Strategic Preparedness and Response; and Biomedical Advanced Research and Development Authority, under contract number HHSO100201500029C. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Department of Health and Human Services or its components. This research project receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement number 115620, resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/2007–2013) and European Federation of Pharmaceutical Industries and Associations companies in kind contribution, under the COMBACTE-CARE consortium. Aztreonam–avibactam is jointly developed with AbbVie. Results from this study were presented at IDWeek 2023 (Oct 11–15, 2023) in Boston, MA, USA., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Assessment of decadal changes in coastal nitrogen sources in NW Spain with stable isotopes in macroalgae and mussels

  • Bode, Antonio
  • García-Seoane, Rita
  • Varela, Zulema
  • Viana, Inés G.
[Data Availability]: Upwelling index values are available at http://www.indicedeafloramiento.ieo.es. Hydrographic data are available at https://doi.org/10.1594/PANGAEA.919087 and at https://cdi.seadatanet.org/csr/ (project RADIALES). Stable isotope data are available at https://doi.org/10.1594/PANGAEA.974186 and https://doi.org/10.1594/PANGAEA.974299, Upwelling is one of the major mechanisms responsible for the input of nutrients sustaining high levels of marine primary production. As a consequence of global change, variations in upwelling intensity may affect nutrient supply thus impacting marine food webs. In this study, we examine the effects of decadal variability of upwelling strength on nitrate supply and its influence on the nitrogen stable isotope composition at the base of the marine food web at the northern boundary of the Canary Current upwelling system (NW Spain) between 1989 and 2023. The study focused on the early upwelling season each year (March-June) to minimize the effects of nitrogen remineralization. Intertidal macroalgae (Phaeophyceae) and mussels (Mytilus galloprovincialis) were used as proxies for temporally integrated isotopic signals of nitrogen sources (δ15N). While no significant temporal trends for either upwelling strength, nitrate concentrations, or stable isotopes were found, three periods with characteristic upwelling and nutrient regimes were identified. A linear increase in δ15N, particularly in Fucus spp., associated with a decreasing contribution of upwelling-derived nitrogen suggest the influence of additional sources, likely of anthropogenic origin. Thus, no net change in productivity would be expected in this region despite quasi-decadal shifts in upwelling dynamics. Further insights on the origin and relevance of these sources can be gained through the investigation of river and runoff inputs and the use of more sensitive tracers, such as amino acid δ15N analysis in mussels., This research was supported by Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033 Spain) through project QLOCKS (PID2020-115620RB-100), and additional funds by the Consellería de Medio Ambiente (Galicia, Spain) through the 3rd phase of the Environmental Specimen Bank (2000–2004), the Competitive Reference Group GRC GI-1252/GPC2020-23 (ED431C 2020/19), co-funded by the Xunta de Galicia (Spain) and the European Regional Development Fund (ERDF, EU), and postdoctoral research grants Juan de la Cierva-Incorporación to I.G.V. (IJC2019-040554-I), Juan de la Cierva-Formación to R.G.S. (FJC2019-040921-I), and María Zambrano Programme of the Spanish Ministry of Universities to Z.V. R.G.S also received funds from the European Union NextGenerationEU/PRTR programmes and is currently supported by the Horizon Europe research and innovation programme under a Marie Skłodowska-Curie Postdoctoral Fellowship 2023 (101150001-PelCon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

BioTIME 2.0: Expanding and Improving a Database of Biodiversity Time Series

  • Dornelas, María
  • Antão, Laura H.
  • Bates, Amanda E.
  • Brambilla, Viviana
  • Chase, Jonathan M.
  • Chow, Cher F. Y.
  • Fontrodona-Eslava, Ada
  • Magurrán, Anne E.
  • Martins, Inês S.
  • Moyes, Faye
  • Sagouis, Alban
  • Peñuelas, Josep
  • Pereira, Felipe Walter
  • Peroni, Nivaldo
  • Picó, Sergio
  • Pilotto, Francesca
  • Dwyer, Ciara
  • Tercio Pinheiro, Hudson
  • Pizarro, Oscar
  • Pizzolotto, Roberto
  • Holeck, Kristen T.
  • Macdonald, S. Ellen
  • Barbosa, Miguel
  • Pomati, Francesco
  • Santos Pompeu, Paulo
  • Ponton, Dominique
  • Post, Eric
  • Poulet, Nicolas
  • Pöyry, Juha
  • Earl, Stevan
  • Presley, Steven J.
  • Prins, Herbert H. T.
  • Madin, Joshua S.
  • Robertson Anderson, Madelaine Jean
  • Provoost, Pieter
  • Prudic, Kathleen L.
  • Barlow, Jos
  • Punjayil, Vignesh
  • Pyšek, Petr
  • Querner, Pascal
  • Quimbayo, Juan Pablo
  • Ramnarine, Indar W.
  • Edelist, Dor
  • Barroso Magalhães, André Lincoln
  • Reed, Daniel C.
  • Davis, Robert A.
  • Reich, Peter Bernard
  • Remillard, Suzanne M.
  • Richards, Cerren
  • Richardson, Anthony James
  • Bässler, Claus
  • Rijn, Itai van
  • Rivera-Monroy, Victor H.
  • Rixen, Christian
  • Mahabir, Rajindra
  • Robinson, Kevin Peter
  • Edgar, Graham John
  • Hollister, Robert D.
  • Rocha, Ricardo
  • Rodrigues, Ricardo R.
  • Rodrigues, Cassy
  • Roos, Bjørn de
  • Rossa-Feres, Denise C.
  • Rosselli, Loreta
  • Beaumont, Matthieu
  • Maphisa, David
  • Rothlisberg, Peter Charles
  • Rubio, Ana
  • Rudstam, Lars G.
  • Holmes, Richard T.
  • Edmondson, Sally
  • Ruz, Catalina S.
  • Rybicki, Nancy B.
  • Ryckegem, Gunther Van
  • Rypel, Andrew L.
  • Sadler, Jon P.
  • Badihi, Gal
  • Satoru Saito, Victor
  • Sal, Sofia
  • Beenaerts, Natalie
  • Portela Salomão, Renato
  • Hoogenboom, Mia Odell
  • Sanders, Nathan J.
  • Elgin, Ashley K.
  • Santos, Flavio A. M.
  • Gomes dos Santos, Tiago
  • Kumar Sarker, Swapan
  • Martin, Thomas Edward
  • Scanga, Sara E.
  • Schaub, Marcus
  • Schmidt, Jochen
  • Kappel Schmidt, Inger
  • Schooley, Robert L.
  • Hortal, Joaquín
  • Begot, Tiago Octavio
  • Schultz, Alfred
  • Acquah-Lamptey, Daniel
  • Scotti, Alberto
  • Martins, Marcio
  • Serpell-Stevens, Amanda
  • Serrano, Filipe C.
  • Shadwick, Elizabeth H.
  • Shaft, Matthew
  • Sherry, Thomas W.
  • Mayumi Shimabukuro, Erika
  • Horton, Tammy
  • Siciński, Jacek
  • Sievers, Caya
  • Beiroz, Wallace
  • Martone, Patrick T.
  • Ellingsen, Kari Elsa
  • Rodrigues da Silva, Fernando
  • Silva, Ana Carolina da
  • Silveira, Juliana M.
  • Siqueira, Tadeu
  • Kavidapadinjattathil Sivadasan, Arunkumar
  • Parambil Sivan, Prasad Theruvil
  • Hsieh, Chih-hao
  • Skuja, Agnija
  • Slaughter, Amalia L.
  • Dickman, Christopher R.
  • Slingsby, Jasper A.
  • Smith, Joseph R.
  • Elmendorf, Sarah C.
  • Beldade, Ricardo
  • Soares, Bruno Eleres
  • Solan, Martin
  • Maluf Souza, Flaviana
  • Souza, Gabriel B. G.
  • Huffard, Christine L.
  • Sprague, Joshua L.
  • Havstad, Kris
  • Stachowk, Ulrich
  • Stadt, J. John
  • Stallings, Christopher D.
  • Stanchev, Radoslav Hristov
  • Eriksen, Ruth S.
  • Stanley, Emily H.
  • Bell, David M.
  • Starzomski, Brian M.
  • Sterza, Jose Mauro
  • Huikkonen, Ida-Maria
  • Matesanz, Silvia
  • Stevens, Maarten
  • Stiles, F. Gary
  • Stoll, Stefan
  • Stuart-Smith, Rick D.
  • Rondon Súarez, Yzel
  • Super, Laura
  • Ernest, S. K. Morgan
  • Supp, Sarah R.
  • Sutela, Tapio
  • Bellgrove, Alecia
  • Matsuzaki, Shin-ichiro S.
  • Hurlbert, Allen H.
  • Suthers, Iain M.
  • Suuronen, Anna
  • Swadling, Kerrie M.
  • Szydlowski, Daniel K.
  • Taki, Hisatomo
  • Taylor Sara Jeanne Snell
  • Tedesco, Pablo A.
  • Escribano, Ruben
  • Teichert, Nils
  • Matthews, Thomas J.
  • Terui, Akira
  • Hynes, Julian
  • Thiede, Gary P.
  • Belmaker, Jonathan
  • Thimonier, Anne
  • Thomas, Oliver
  • Thompson, Peter Allan
  • Thorn, Simon
  • Tiemann, Jeremy S.
  • Toledo, Luís Felipe
  • McCombe Matthews, Iain
  • Cabral Eterovick, Paula
  • Tolvanen, Anne
  • Day, Frank P.
  • Zugliani Toniato, Maria Teresa
  • Torre, Ignasi
  • Tortato, Marcos Adriano
  • Benedetti-Cecchi, Lisandro
  • Totsu, Kumiko
  • Trant, Andrew
  • Twilley, Robert R.
  • Maxwell, Connie J.
  • Urabe, Hirokazu
  • Valade, Pierre
  • Evans, Brian S.
  • Antunes, Alexsander Z.
  • Valdivia, Nelson
  • Vallejo, Martha Isabel
  • Valone, Thomas J.
  • Vanaverbeke, Jan
  • Silveira Vasconcelos, Tiago
  • Benkwitt, Cassandra E.
  • McFarland, Kent P.
  • Vehanen, Teppo
  • Venturoli, Fábio
  • Verheye, Hans M.
  • Vermeulen, Hendrik Jannes Wietse
  • Irz, Pascal
  • Everett, Jason D.
  • Verstraeten, Arne
  • Vianna, Marcelo
  • Vieira, Rui
  • Vieira-Alencar, João Paulo Santos
  • McGill, Brian J.
  • Vilella, Marc
  • Vitule, Jean Ricardo Simões
  • Medina-van Berkum, Pamela
  • Vu, Lien Van
  • Waide, Robert B.
  • Macedo Ivanauskas, Natalia
  • Warren, Paige S.
  • Evtimova, Vesela
  • Wayman, Joseph Paul
  • Webb, Sara L.
  • Bailey, Joseph J.
  • Weigel, Benjamin
  • Welti, Ellen A. R.
  • West, Fritha
  • Westermann, Fulgor
  • Whalen, Matthew A.
  • Bestelmeyer, Brandon T.
  • Iwayama, Akemi
  • White, Ethan P.
  • Widdicombe, Claire E.
  • Exton, Dan A.
  • McKnight, Diane Marie
  • Williams, Richard
  • Williamson, Mark
  • Willig, Michael R.
  • Wipf, Sonja
  • Woehler, Eric J.
  • Woldering, Alje
  • Woods, Kerry D.
  • James, Darren K.
  • Xu, Wu-Bing
  • Betts, Matthew G.
  • McWilliam, Michael J.
  • Yahel, Ruthy
  • Adam, Dušan
  • Yang, Zeren
  • Zawada, Kyle J. A.
  • Zornosa-Torres, Camila
  • Zvuloni, Assaf
  • Billah, Maxwell Kelvin
  • Bjorkman, Anne D.
  • Jandt, Ute
  • Błażewicz, Magdalena
  • Hermanutz, Luise
  • Bloch, Christopher P.
  • Blowes, Shane A.
  • Bode, Antonio
  • Fairbairn, Andrew J.
  • Bogoni, Juliano A.
  • Bolger, Thomas
  • Bonebrake, Timothy C.
  • Bonsdorff, Erik
  • Bottarin, Roberta
  • Jażdżewska, Anna M.
  • Dirilgen, Tara
  • Brokensha, Luke N.
  • Brooker, Rob W.
  • Brooks, Andrew J.
  • Bruelheide, Helge
  • Almeida Bueno, Thiago
  • Moreli Fantacini, Felipe
  • Laguionie, Claire
  • Lopes Campagnoli, Mariana
  • Cant, James
  • Pellegrini Caramaschi, Erica
  • Meador, Jason
  • Jocque, Merlijn
  • Caron, Alexandre
  • Carroll, Tadhg
  • Caruso, Tancredi
  • Carvajal-Quintero, Juan
  • Castaldelli, Giuseppe
  • Castañeda-Moya, Edward
  • Turini Farah, Fabiano
  • Castilho, Pedro V.
  • Zanini Cechin, Sonia
  • Meesenburg, Henning
  • Chaikin, Shahar
  • Johnston, Sophie T.
  • Manjunatha Chandrashekara, Uchangi
  • Chase, Tory J.
  • Chen, Chaolun Allen
  • Cherem, Jorge José
  • Choi, Sei-Woong
  • Christensen, Erica M.
  • Christianini, Alexander V.
  • Zanella Farneda, Fábio
  • Meier, Kristin
  • Wing Four Chu, Jackson
  • Coad, Peter
  • Jones, Samuel E. I.
  • Colen, Carl Van
  • Comte, Lise
  • Cooper, Elisabeth J.
  • Cornelissen, J. Hans C.
  • Cosson, Eddy
  • Cotano, Unai
  • Crevecoeur, Luc
  • Melecis, Viesturs
  • Crow, Shannan Kyle
  • Favila, Mario E.
  • Cumming, Graeme S.
  • De-La-Zerda, Sussy
  • Daga, Vanessa S.
  • Damasceno, Gabriella
  • Daskalova, Gergana N.
  • Davies, Claire H.
  • Fernandez-Fournier, Philippe
  • Fernández-Zapata, Braulio
  • Meserve, Peter L.
  • Ferreira, Diogo F.
  • Ferronato, Carola
  • Feu, Christopher R. du
  • Ajani, Penelope A.
  • Jones, Faith A. M.
  • Fidelis, Alessandra
  • Fifield, David A.
  • Picinatto Filho, Vilmar
  • Mesquita Filho, Walter
  • Fitt, Robert N. L.
  • Meyer, Christoph F. J.
  • Flechtmann, Carlos A. H.
  • Fraser, William R.
  • Fraser, Donna L.
  • Freixas, Lídia
  • Fryxell, John
  • Arismendi, Iván
  • Albaina, Aitor
  • Fundakowski, Garrett J.
  • Gabara, Scott Stanley
  • Gallois, Elise
  • Michelsen, Anders
  • García Criado, Mariana
  • García-Berthou, Emili
  • Garrabou, Joaquim
  • Gates, Andrew R.
  • Cazzolla Gatti, Roberto
  • Gavioli, Anna
  • Jones, Julia A.
  • Gavriel, Tal
  • Almaraz, Pablo
  • Gendreau-Berthiaume, Benoit
  • Miiller, Natali Oliva Roman
  • Giam, Xingli
  • Gjerdrum, Carina
  • Glemnitz, Michael
  • Godbold, Jasmin Annica
  • Gómez-Gras, D.
  • Barbosa Gonçalves, Rodrigo
  • Goold, Andy
  • Jucevica, Edite
  • Gordon, Richard R.
  • Goren, Menachem
  • Baird, Andrew H.
  • An, Jeongseop
  • Vilas Boas Goulart, Fernando
  • Gould, William A.
  • Grabowski, Meagan M.
  • Graham, Nicholas A. J.
  • Graipel, Maurício Eduardo
  • Grange, Laura J.
  • Greenville, Aaron C.
  • Kagainis, Ugis
  • Grossman, Gary D.
  • Hickford, Michael Julian Hames
  • Guinder, Valeria A.
  • Haase, Peter
  • Anderson, Roger Sigismund
  • Haskins, Gary N.
  • Kagami, Maiko
  • Kang, Jungwon
  • Ke, Xuejia
  • Keeley, Erin Colleen
  • Kinnear, Rebecca
  • Deacon, Amy Elizabeth
  • Milardi, Marco
  • Klanderud, Kari
  • Klinck, Uwe
  • Armbrecht, Linda
  • Klink, Roel van
  • Klotz, Stefan
  • Knockaert, Carolien
  • Knutsen, Halvor
  • Koivula, Matti
  • Kortz, Alessandra
  • Kriegel, Peter
  • Adu-Acheampong, Samuel
  • Castro-Arrazola, Indradatta de
  • Kuo, Chao-Yang
  • Kushner, David J.
  • Kyerematen, Rosina
  • Aros-Mardones, Pedro
  • Lagarde, Raphaël
  • Lancaster, Lesley T.
  • Landau, Ori Frid
  • Landuyt, Wouter Van
  • Larson, Eric R.
  • Milchakova, Nataliya
  • Lazarus, Mai
  • Degraer, Steven
  • Lee, Cheol Min
  • Lefcheck, Jonathan S.
  • Lembrechts, Jonas J.
  • Lima, Renato A. F.
  • Ashtamoorthy, Sreejith Kalpuzha
  • Guimarães Lima, Romullo
  • Lima, Nathália G. S.
  • Linares, Cristina
  • Miller, Robert J.
  • Lindstrom, Sandra C.
  • Lloret, Francisco
  • Deonarinesingh, Kharran
  • Lloyd, John David
  • Cardoso Lobato, Cleonice Maria
  • Lodge, David M.
  • Long, Peter Richard
  • López-Abbate, Celeste
  • Ayyappan, Narayanan
  • López-Baucells, Adrià
  • Millett, Jonathan
  • Louzada, Julio
  • Louzao, Maite
  • Lugliè, Antonella
  • Díaz Ricaurte, Juan C.
  • Ribeiro Luiz, Micheli
  • Moens, Tom
  • Montag, Luciano F. A.
  • Moore, Jon
  • Müller, Jörg
  • Murali, Akhil
  • Hidalgo, Pamela
  • Murray, Shauna Ann
  • Baird, Mark Edward
  • Dolan, Ciaran John
  • Myers-Smith, Isla H.
  • Myster, Randall W.
  • Nakamura, Masahiro
  • Nayar, Sasi
  • Neat, Francis
  • Nelson, James A.
  • Nelson, Michael Paul
  • Higuchi, Pedro
  • Nikolov, Boris P.
  • Nouioua, Rym
  • Nsor, Collins Ayine
  • Duffy, J. Emmett
  • Balakrishnan, Sreekumar Vadakkethil
  • O'Connor, Michael
  • Adzesiwor Obodai, Edward
  • Offland, Amy Marie
  • Ogaya, Romá
  • Ogura, Hisako
  • Hoey, Andrew S.
  • Okey, Thomas A.
  • Olden, Julian D.
  • Rodrigues Oliveira-Santos, Luiz Gustavo
  • Oliver, Jeffrey C.
  • Dunn, Timothy E.
  • Moland Olsen, Esben
  • Barão-Nóbrega, José António L.
  • Onipchenko, Vladimir G.
  • Oro, Daniel
  • Ozolins, Davis
  • Van Hoey, Gert
  • Pabis, Krzysztof
  • Padedda, Bachisio Mario
  • Palacio, Facundo X.
  • Paquette, Alain
  • Trilestari Pardede, Sinta
  • Durigan, Giselda
  • Paterson, David M.
  • Pausina, Sarah
  • Barash, Adi
  • Pélissier, Raphaël
  • Hofgaard, Annika
  • Pennings, Steven C.
18 pages, 4 figures, supporting information https://doi.org/10.1111/geb.70003.-- Data Availability Statement: A static stable release of BioTIME version 2.0 can be found in Zenodo (https://doi.org/10.5281/zenodo.10932823). Code used in data curation and standardisation can be found at github.com/bioTIMEHub/BioTIME. The R package BioTIMEr is available in CRAN and can be found at github.com/bioTIMEHub/BioTIMEr, Motivation: Here, we make available a second version of the BioTIME database, which compiles records of abundance estimates for species in sample events of ecological assemblages through time. The updated version expands version 1.0 of the database by doubling the number of studies and includes substantial additional curation to the taxonomic accuracy of the records, as well as the metadata. Moreover, we now provide an R package (BioTIMEr) to facilitate use of the database. Main Types of Variables Included: The database is composed of one main data table containing the abundance records and 11 metadata tables. The data are organised in a hierarchy of scales where 11,989,233 records are nested in 1,603,067 sample events, from 553,253 sampling locations, which are nested in 708 studies. A study is defined as a sampling methodology applied to an assemblage for a minimum of 2 years. Spatial Location and Grain: Sampling locations in BioTIME are distributed across the planet, including marine, terrestrial and freshwater realms. Spatial grain size and extent vary across studies depending on sampling methodology. We recommend gridding of sampling locations into areas of consistent size. Time Period and Grain: The earliest time series in BioTIME start in 1874, and the most recent records are from 2023. Temporal grain and duration vary across studies. We recommend doing sample-level rarefaction to ensure consistent sampling effort through time before calculating any diversity metric. Major Taxa and Level of Measurement: The database includes any eukaryotic taxa, with a combined total of 56,400 taxa. Software Format: csv and. SQL, The BioTIME project was funded since conception by the European Research Council grant AdG BioTIME 250189 awarded to A.E.M., European Research Council grant PoC BioCHANGE 727440 awarded to A.E.M. and M.D., European Research Council grant AdG MetaCHANGE 101098020 awarded to J.C. and the Leverhulme Centre for Anthropocene Biodiversity grant RC-2018-021 awarded to M.D. These funds partially supported V.B., C.C., A.F.E. and F.M. A.F.E. was supported by the Fisheries Society of the British Isles Studentship. V.B. and M.D. were partially supported by European Research Council grant CoralINT 101044975. [...] Funding to A. Bode was provided by projects RADIALES (IEO-CSIC) and QLOCKS (PID2020-115620RB-100 MCIN/AEI/10.13039/501100011033, Spain). [...] I. deCastro-Arrazola was funded by a FPI grant from the Spanish Ministry of Science and Innovation (BES-2012-054353). Surveys and data processing were supported by the Spanish Agency of Innovation (AEI) project SCARPO (grant no.: CGL2011-29317). [...] J. Penuelas was supported by Spanish government grant PID2022-140808NB-I00, This work contributes to the Institut de Ciències del Mar "Severo Ochoa Centre of Excellence" accreditation CEX2024-001494-S funded by AEI 10.13039/501100011033 of the Spanish Ministry of Science and Innovation, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

BioTIME 2.0: expanding and improving a database of biodiversity time series (V.4) [Dataset]

  • BioTIME
  • Almaraz, Pablo
  • Bode, Antonio
  • Chaikin, Shahar
  • Castro-Arrazola, Indradatta de
  • Garrabou, Joaquim
  • Hortal, Joaquín
  • Ogaya, Romá
  • Oro, Daniel
  • Peñuelas, Josep
We include here: - SQL file of the database - biotime_v2_sql_15April25.sql - RDS file of the query combining raw data with species names - biotime_v2_query_15April25.rds - csv file for metadata information - biotime_v2_metadata_15April25.csv - csv file of citations - references_biotime_v2_15April25.csv - text file of BIB text citations - BIB_biotime_v2_15April25.csv.txt, Here we make available a second version of the BioTIME database, which compiles records of abundance estimates for species in sample events of ecological assemblages through time. The updated version expands version 1.0 of the database by doubling the number of studies in the database, and includes substantial additional curation to the taxonomic accuracy of the records, as well as the metadata. Moreover, we now provide an R package (BioTIMEr) to facilitate use of the database, Funding to A. Bode was provided by projects RADIALES (IEO-CSIC) and QLOCKS (PID2020-115620RB-100 MCIN/AEI/10.13039/501100011033, Spain). [...] I. de Castro-Arrazola was funded by a FPI grant from the Spanish Ministry of Science and Innovation (BES-2012-054353). Surveys and data processing were supported by the Spanish Agency of Innovation (AEI) project SCARPO (grant no.: CGL2011-29317). [...] J. Penuelas was supported by Spanish government grant PID2022-140808NB-I00, This work contributes to the Institut de Ciències del Mar "Severo Ochoa Centre of Excellence" accreditation CEX2024-001494-S funded by AEI 10.13039/501100011033 of the Spanish Ministry of Science and Innovation, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Trophic niche characterization of zooplankton and planktivorous fish: a comparative approach using stable isotopes in bulk and amino acid samples

  • Mondéjar, Nuria
  • Viana, Inés G.
  • García-Seoane, Rita
  • Otero, Jaime
  • Bode, Antonio
[Data availability statement] The datasets presented in this study can be found in online repositories. The raw data on upwelling strength computed by the Instituto Español de Oceanografı́a (IEO-CSIC) is available at http://www.indicedeafloramiento.ieo.es. Satellite sea surface temperature and chlorophyll-a concentrations were obtained from the NOAA Earth System Research Laboratory (https://psl.noaa.gov/data/gridded/data.noaa.oisst.v2.highres.html) and from the GlobColour Project (https://hermes.acri.fr/), respectively. Stable isotope data is available at the PANGAEA repository (https://doi.pangaea.de/10.1594/PANGAEA.985234)., Correction: Trophic niche characterization of zooplankton and planktivorous fish: a comparative approach using stable isotopes in bulk and amino acid samples, https://doi.org/10.3389/fmars.2026.1799156, Quantification of the size and overlap of trophic niches of species with similar diets is crucial to understand food web dynamics. However, there are difficulties in determining all food resources used by each species over time and resolving competition suggested by niche overlap. In this study, we compare niche estimations in zooplankton and four species of planktivorous fish using stable carbon and nitrogen isotopes analyzed in bulk tissue samples with those using stable nitrogen isotopes in amino acids. Samples were collected in spring 2021 and 2022 in two areas of the northwestern Iberian shelf (Galicia) and southern Bay of Biscay (mar Cantábrico) with different influence of the seasonal upwelling. Estimations of trophic niches using both methods were complementary, revealing interspecific differences among fish species in the exploitation of food web resources. For instance, marked differences in the sources of carbon and nitrogen and low niche overlap indicated local feeding for zooplankton and some fish species (sardine and chub mackerel), while other species showed large variability in sources and niche overlap across zones (anchovy and mackerel). The apparent competition of fish species for resources suggested by these results can be explained by differences in their mobility, particularly in mackerel and anchovy, when the isotopic signal is not equilibrated with the new diet., The author(s) declared that financial support was received for this work and/or its publication. PELACUS surveys (Spanish Institute of Oceanography, Spain) are co-funded by the European Union through the Data Collection Framework. This research was supported by MCIN/AEI/10.13039/501100011033 (Spain) through the QLOCKS (PID2020-115620RB-100) and MTL-FISH (PID2023-147149NB100) projects. RG-S. received funding from a Juan de la Cierva-Formación postdoctoral grant (FJC2019-040921-I) from MCIN/AEI and the EU NextGeneration/PRTR programs, as well as from the Spanish Ministry of Science, Innovation and Universities through the José Castillejo mobility program (CAS21/00543). She is currently supported by the European Union’s Horizon Europe research and innovation program under a Marie Skłodowska-Curie Postdoctoral Fellowship 2023 (grant agreement No 101150001-PelCon). IV was supported by a Juan de la Cierva-Incorporación postdoctoral grant (IJC2019-040554-I) from MCIN/AEI. NM was supported by a predoctoral grant (PREP2023-001364) from MCIN/AEI., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Natural abundance of stable carbon and nitrogen isotopes, and lipid composition of small pelagic fishes from Galicia and Southern Bay of Biscay

  • García-Seoane, Rita
  • Viana, Inés G.
  • Bode, Antonio
  • Close, Hilary G.
This dataset contains the values of natural abundance of stable carbon and nitrogen isotopes in bulk tissues, carbon values in total lipid extracts and lipid fractions, nitrogen values in amino acids, as well as the fatty acid profiles from the total lipid extracts and lipid fractions measured in 33 samples of 4 small pelagic fishes sampled during the PELACUS0322 cruise (NE Atlantic, April 2022). Six capture sites were distributed over 4 sampling zones in Galicia and in adjacent waters of the southern Bay of Biscay. Length, weight, sex and maturity stage data for each individual analyzed are also provided. Fishes were collected by midwater trawls of ca. 30 m² pelagic net equipped with a graded-mesh netting (starting with 30 mm and ending with 4 mm). The duration of each trawl was between 25 and 40 min. Different species occurred in the same trawls. Samples of muscle tissue were preserved freeze-dried. No treatments for lipid removal were used prior to carbon analyses. Lipids were extracted from freeze‐dried aliquots using a modified version of the Bligh and Dyer (1959) method. Neutral and polar lipid fractions from the total lipid extracts were separated by adsorption chromatography on a silica gel micro-column (100–200 mesh, 60 Å, pre-combusted silica gel) using solvents of different polarities. Stable isotope determinations (also carbon and nitrogen contents) were made by isotope-ratio mass spectrometry using an elemental analyzer (bulk samples and lipid extracts; Close et al. 2014; Bode et al. 2018) or a gas-chromatograph (derivatized amino acids; Bode et al. 2021) as the inlet device. Identification and quantification of fatty acids were made by gas-chromatography mass-spectrometry., Agencia Estatal de Investigación (AEI), grant/award no. FJC2019-040921-I: Postdoctoral research grant Juan de la Cierva-Formación Agencia Estatal de Investigación (AEI), grant/award no. IJC2019-040554-I: Postdoctoral research grant Juan de la Cierva-Incorporación Agencia Estatal de Investigación (AEI), grant/award no. PID2020-115620RB-100: QLOCKS project Spanish Ministry of Science, Innovation and Universities (MICINN), grant/award no. CAS21/00543: Mobility grant José Castillejo, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Downwelling persistence modifies nitrogen sources available for benthic food webs

  • Bode, Antonio
  • Otero, Jaime
  • Viana, Inés G.
In highly productive coastal ecosystems, new nitrogen inputs by coastal upwelling can be overridden at times by those from other sources. Determination of these sources is important to understand changes in food web structure and productivity. In this study, the relative importance of upwelling dynamics and continental waters as nitrogen sources for coastal food webs at annual time scales was analyzed in Galicia (NW Spain). Stable nitrogen isotopes of bulk tissue in macroalgae and of amino acids in mussels, as proxies for the preferred source for growth, were compared with a time series of nutrient and oceanographic observations. When upwelling dominated during all seasons, the low isotopic enrichment in organisms was consistent with the use of oceanic nitrate from Eastern North Atlantic Central Waters (ENACW) as the main source of new nitrogen in shelf waters. In contrast, when downwelling dominated in autumn and winter, the large fraction of coastal nitrate unrelated to ENACW and the high isotopic enrichment in organisms suggested the assimilation of additional nitrogen sources. Incomplete nitrate uptake and denitrification in sediments were identified as potential sources of isotopically enriched nitrate in the downwelling-dominated period. Other nitrate sources, such as strong winter mixing or continental inputs related to precipitation appeared to play a minor role because the precipitation regimes and surface nitrate concentrations were similar in both periods. This study pointed out the importance of persistent and intense autumn and winter downwelling for nutrient retention in coastal waters. The proposed mechanisms, while speculative, would require further attention in future studies., We are indebted to all participants in the environmental time series project RADIALES- section of A Coruña. Particularly, we acknowledge the collaboration of C. Carballo, N. González, M. Castaño, L. Vázquez, and M. Álvarez involved in the analysis of inorganic nutrients and oxygen of the RADIALES series., This research was supported by Agencia Estatal de Investigación (Spain) (MCIN/AEI/10.13039/501100011033) through project QLOCKS (PID2020-115620RB-100), and by the RADIALES project (RADIALNW-35F-ESMARES3) of IEO-CSIC, co-funded by the Ministerio de Transición Ecológica (Spain) and by the European Maritime, Fisheries and Aquaculture Fund (EMFAF). I.G.V received at postdoctoral research grant Juan de la Cierva-Incorporación (IJC2019-040554-I) from MCIN/AEI and additional funds from the European Union Interreg Program VI-A España-Portugal (POCTEP) 2021–2027 through project CAPTA (0062_CAPTA_1_E)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

PRAISE: providing a roadmap for automated infection surveillance in Europe

  • van Mourik, Maaike S. M.
  • van Rooden, Stephanie M.
  • Abbas, Mohamed
  • Aspevall, Olov
  • Astagneau, Pascal
  • Bonten, Marc J.M.
  • Carrara, Elena
  • Gomila Grange, Aina
  • de Greeff, Sabine C.
  • Gubbels, Sophie
  • Harrison, Wendy
  • Humphreys, Hilary
  • Johansson, Anders
  • Koek, Mayke B.G.
  • Kristensen, Brian
  • Lepape, Alain
  • Lucet, Jean-Christophe
  • Mookerjee, Siddharth
  • Naucler, Pontus
  • Palacios Baena, Zaira R.
  • Presterl, Elisabeth
  • Pujol Rojo, Miquel
  • Reilly, Jacqui
  • Roberts, Christopher
  • Tacconelli, Evelina
  • Teixeira, Daniel
  • Tängdén, Thomas
  • Valik, John Karlsson
  • Behnke, Michael
  • Gastmeier, Petra
Introduction: Healthcare-associated infections (HAI) are among the most common adverse events of medical care. Surveillance of HAI is a key component of successful infection prevention programmes. Conventional surveillance - manual chart review - is resource intensive and limited by concerns regarding interrater reliability. This has led to the development and use of automated surveillance (AS). Many AS systems are the product of in-house development efforts and heterogeneous in their design and methods. With this roadmap, the PRAISE network aims to provide guidance on how to move AS from the research setting to large-scale implementation, and how to ensure the delivery of surveillance data that are uniform and useful for improvement of quality of care. Methods: The PRAISE network brings together 30 experts from ten European countries. This roadmap is based on the outcome of two workshops, teleconference meetings and review by an independent panel of international experts. Results: This roadmap focuses on the surveillance of HAI within networks of healthcare facilities for the purpose of comparison, prevention and quality improvement initiatives. The roadmap does the following: discusses the selection of surveillance targets, different organizational and methodologic approaches and their advantages, disadvantages and risks; defines key performance requirements of AS systems and suggestions for their design; provides guidance on successful implementation and maintenance; and discusses areas of future research and training requirements for the infection prevention and related disciplines. The roadmap is supported by accompanying documents regarding the governance and information technology aspects of implementing AS. Conclusions: Large-scale implementation of AS requires guidance and coordination within and across surveillance networks. Transitions to large-scale AS entail redevelopment of surveillance methods and their interpretation, intensive dialogue with stakeholders and the investment of considerable resources. This roadmap can be used to guide future steps towards implementation, including designing solutions for AS and practical guidance checklists.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study

  • Vallejo Torres, Laura
  • Pujol Rojo, Miquel
  • Shaw Perujo, Evelyn
  • Wiegand, Irith
  • Vigo, Joan Miquel
  • Stoddart, Margaret
  • Grier, Sally
  • Gibbs, Julie
  • Vank, Christiane
  • Cuperus, Nienke
  • van den Heuvel, Leonard
  • Eliakim-Raz, Noa
  • Carratalà, Jordi
  • Vuong, Cuong
  • MacGowan, Alasdair
  • Babich, Tanya
  • Leibovici, Leonard
  • Addy, Ibironke
  • Morris, S. (Stephen), 1971-
  • RESCUING Study Group and Study Sites
Objective: Complicated urinary tract infections (cUTIs) impose a high burden on healthcare systems and are a frequent cause of hospitalisation. The aims of this paper are to estimate the cost per episode of patients hospitalised due to cUTI and to explore the factors associated with cUTI-related healthcare costs in eight countries with high prevalence of multidrug resistance (MDR). Design: This is a multinational observational, retrospective study. The mean cost per episode was computed by multiplying the volume of healthcare use for each patient by the unit cost of each item of care and summing across all components. Costs were measured from the hospital perspective. Patient-level regression analyses were used to identify the factors explaining variation in cUTI-related costs. Setting: The study was conducted in 20 hospitals in eight countries with high prevalence of multidrug resistant Gram-negative bacteria (Bulgaria, Greece, Hungary, Israel, Italy, Romania, Spain and Turkey). Participants: Data were obtained from 644 episodes of patients hospitalised due to cUTI. Results: The mean cost per case was 5700, with considerable variation between countries (largest value 7740 in Turkey; lowest value 4028 in Israel), mainly due to differences in length of hospital stay. Factors associated with higher costs per patient were: type of admission, infection source, infection severity, the Charlson comorbidity index and presence of MDR. Conclusions: The mean cost per hospitalised case of cUTI was substantial and varied significantly between countries. A better knowledge of the reasons for variations in length of stays could facilitate a better standardised quality of care for patients with cUTI and allow a more efficient allocation of healthcare resources. Urgent admissions, infections due to an indwelling urinary catheterisation, resulting in septic shock or severe sepsis, in patients with comorbidities and presenting MDR were related to a higher cost.